kqucikaqpamaksfqbiwcoopcyezihafqqogoqssi length 6 154668 page 154668 <!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="minimum-scale=1, initial-scale=1, width=device-width"/><link rel="icon" href="/assets/favicon/favicon16.png" sizes="16x16"/><link rel="icon" href="/assets/favicon/favicon32.png" sizes="32x32"/><link rel="icon" href="/assets/favicon/favicon128.png" sizes="128x128"/><link rel="icon" href="/assets/favicon/favicon152.png" sizes="152x152"/><link rel="icon" href="/assets/favicon/favicon167.png" sizes="167x167"/><link rel="icon" href="/assets/favicon/favicon180.png" sizes="180x180"/><link rel="icon" href="/assets/favicon/favicon192.png" sizes="192x192"/><link rel="icon" href="/assets/favicon/favicon196.png" sizes="196x196"/><link rel="icon" href="/assets/favicon/favicon512.png" sizes="512x512"/><title>What’s Next In The Ozempic Era? | Discover Magazine</title><meta name="user-type" content="anonymous"/><script type="application/ld+json">{"@context":"https://schema.org","@type":"Organization","name":"Discover Magazine","url":"https://www.discovermagazine.com","logo":{"@type":"ImageObject","url":"https://www.discovermagazine.com/assets/globalAssets/siteLogo.png","width":"224px","height":"64px"},"sameAs":["https://www.facebook.com/DiscoverMag","https://twitter.com/discovermag","https://www.instagram.com/discover.magazine/","https://www.youtube.com/user/discovermagazine","https://soundcloud.com/its-only-science-discover-magazine"]}</script><meta name="description" content="Diabetes, weight loss and now heart health: A new family of drugs is changing the way scientists are thinking about obesity — and more uses are on the horizon"/><meta property="og:title" content="What’s Next In The Ozempic Era?"/><meta property="og:description" content="Diabetes, weight loss and now heart health: A new family of drugs is changing the way scientists are thinking about obesity — and more uses are on the horizon"/><meta property="og:image" content="https://images.ctfassets.net/cnu0m8re1exe/64FrvaM7dXAkdp1SirxJMG/fb905076e6fb05b3e4f3892b6be0e369/ozempic-8282315_1280.jpg"/><meta property="og:url" content="https://www.discovermagazine.com/health/whats-next-in-the-ozempic-era"/><meta property="og:site_name" content="Discover Magazine"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:site" content="@DiscoverMag"/><meta name="twitter:creator"/><meta name="twitter:title" content="What’s Next In The Ozempic Era?"/><meta name="twitter:description" content="Diabetes, weight loss and now heart health: A new family of drugs is changing the way scientists are thinking about obesity — and more uses are on the horizon"/><meta name="twitter:image:src" content="https://images.ctfassets.net/cnu0m8re1exe/64FrvaM7dXAkdp1SirxJMG/fb905076e6fb05b3e4f3892b6be0e369/ozempic-8282315_1280.jpg"/><meta name="twitter:image:alt" content="Image by Markus Winkler from Pixabay"/><meta property="fb:app_id" content="2856110197797247"/><link rel="canonical" href="https://www.discovermagazine.com/health/whats-next-in-the-ozempic-era"/><script type="application/ld+json">{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":"https://www.discovermagazine.com/health/whats-next-in-the-ozempic-era","headline":"What’s Next In The Ozempic Era?","articleSection":"Health News","description":"Diabetes, weight loss and now heart health: A new family of drugs is changing the way scientists are thinking about obesity — and more uses are on the horizon","keywords":["wellness"],"url":"https://www.discovermagazine.com/health/whats-next-in-the-ozempic-era","image":"https://images.ctfassets.net/cnu0m8re1exe/64FrvaM7dXAkdp1SirxJMG/fb905076e6fb05b3e4f3892b6be0e369/ozempic-8282315_1280.jpg","thumbnailUrl":"https://images.ctfassets.net/cnu0m8re1exe/64FrvaM7dXAkdp1SirxJMG/fb905076e6fb05b3e4f3892b6be0e369/ozempic-8282315_1280.jpg?fm=jpg&fl=progressive&w=350&h=233&fit=fill","datePublished":"2024-04-25T14:00-05:00","dateModified":"2024-04-25T19:00:02.977Z","author":{"@type":"Person","name":"Matías A. Loewy, Knowable Magazine","url":"https://www.discovermagazine.com/author/matias-a-loewy-knowable-magazine"},"publisher":{"name":"Discover Magazine","@type":"Organization","logo":{"@type":"ImageObject","url":"https://www.discovermagazine.com/assets/globalAssets/siteLogo.png","width":"224px","height":"64px"}},"isAccessibleForFree":"False","hasPart":{"@type":"WebPageElement","isAccessibleForFree":"False","cssSelector":"article"}}</script><script type="application/ld+json">{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://www.discovermagazine.com","name":"Home"}},{"@type":"ListItem","position":2,"item":{"@id":"https://www.discovermagazine.com/health","name":"Health"}},{"@type":"ListItem","position":3,"item":{"@id":"https://www.discovermagazine.com/health/whats-next-in-the-ozempic-era","name":"What’s Next In The Ozempic Era?"}}]}</script><link rel="preload" as="image" href="//images.ctfassets.net/cnu0m8re1exe/64FrvaM7dXAkdp1SirxJMG/fb905076e6fb05b3e4f3892b6be0e369/ozempic-8282315_1280.jpg?fm=jpg&amp;fl=progressive&amp;w=660&amp;h=433&amp;fit=fill"/><meta name="next-head-count" content="32"/><link rel="preconnect" href="https://fonts.gstatic.com"/><link rel="preload" as="style" data-href="https://fonts.googleapis.com/css2?family=Martel:wght@400;600;700&amp;family=Nunito+Sans:wght@400;600;700&amp;family=Fjalla+One:wght@400;500&amp;display=swap"/><link rel="stylesheet" data-href="https://fonts.googleapis.com/css2?family=Martel:wght@400;600;700&amp;family=Nunito+Sans:wght@400;600;700&amp;family=Fjalla+One:wght@400;500&amp;display=swap"/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script src="/_next/static/chunks/webpack-af839d38801e558e.js" defer=""></script><script src="/_next/static/chunks/framework-0fc59b8ee59ea6b8.js" defer=""></script><script src="/_next/static/chunks/main-9e054408e324f7f1.js" defer=""></script><script src="/_next/static/chunks/pages/_app-25174276fc1e01c0.js" defer=""></script><script src="/_next/static/chunks/2b7b2d2a-16715b71c0048900.js" defer=""></script><script src="/_next/static/chunks/689-6dc30b994aad0311.js" defer=""></script><script src="/_next/static/chunks/173-08304f47f283e5b0.js" defer=""></script><script src="/_next/static/chunks/pages/health/%5B%5B...slug%5D%5D-e4552dd56137e248.js" defer=""></script><script src="/_next/static/my-build-id/_buildManifest.js" defer=""></script><script src="/_next/static/my-build-id/_ssgManifest.js" defer=""></script><style data-styled="" data-styled-version="5.3.11">html{line-height:1.15;-webkit-text-size-adjust:100%;}/*!sc*/
body{margin:0;}/*!sc*/
main{display:block;}/*!sc*/
h1{font-size:2em;margin:0.67em 0;}/*!sc*/
hr{box-sizing:content-box;height:0;overflow:visible;}/*!sc*/
pre{font-family:monospace,monospace;font-size:1em;}/*!sc*/
a{background-color:transparent;}/*!sc*/
abbr[title]{border-bottom:none;-webkit-text-decoration:underline;text-decoration:underline;-webkit-text-decoration:underline dotted;text-decoration:underline dotted;}/*!sc*/
b,strong{font-weight:bolder;}/*!sc*/
code,kbd,samp{font-family:monospace,monospace;font-size:1em;}/*!sc*/
small{font-size:80%;}/*!sc*/
sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline;}/*!sc*/
sub{bottom:-0.25em;}/*!sc*/
sup{top:-0.5em;}/*!sc*/
img{border-style:none;}/*!sc*/
button,input,optgroup,select,textarea{font-family:inherit;font-size:100%;line-height:1.15;margin:0;}/*!sc*/
button,input{overflow:visible;}/*!sc*/
button,select{text-transform:none;}/*!sc*/
button,[type="button"],[type="reset"],[type="submit"]{-webkit-appearance:button;}/*!sc*/
button::-moz-focus-inner,[type="button"]::-moz-focus-inner,[type="reset"]::-moz-focus-inner,[type="submit"]::-moz-focus-inner{border-style:none;padding:0;}/*!sc*/
button:-moz-focusring,[type="button"]:-moz-focusring,[type="reset"]:-moz-focusring,[type="submit"]:-moz-focusring{outline:1px dotted ButtonText;}/*!sc*/
fieldset{padding:0.35em 0.75em 0.625em;}/*!sc*/
legend{box-sizing:border-box;color:inherit;display:table;max-width:100%;padding:0;white-space:normal;}/*!sc*/
progress{vertical-align:baseline;}/*!sc*/
textarea{overflow:auto;}/*!sc*/
[type="checkbox"],[type="radio"]{box-sizing:border-box;padding:0;}/*!sc*/
[type="number"]::-webkit-inner-spin-button,[type="number"]::-webkit-outer-spin-button{height:auto;}/*!sc*/
[type="search"]{-webkit-appearance:textfield;outline-offset:-2px;}/*!sc*/
[type="search"]::-webkit-search-decoration{-webkit-appearance:none;}/*!sc*/
::-webkit-file-upload-button{-webkit-appearance:button;font:inherit;}/*!sc*/
details{display:block;}/*!sc*/
summary{display:list-item;}/*!sc*/
template{display:none;}/*!sc*/
[hidden]{display:none;}/*!sc*/
html{box-sizing:border-box;}/*!sc*/
*,*::before,*::after{box-sizing:inherit;}/*!sc*/
a{-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
body{margin:0;font-family:"Nunito Sans",sans-serif;font-size:16px;color:hsl(0,0%,0%);background-color:hsl(0,0%,100%);}/*!sc*/
data-styled.g2[id="sc-global-erQJQW1"]{content:"sc-global-erQJQW1,"}/*!sc*/
.cgZEsQ{color:hsl(0,0%,0%);-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
.cgZEsQ:hover{-webkit-text-decoration:underline;text-decoration:underline;cursor:pointer;}/*!sc*/
.bxBBvR{color:hsl(4,68%,52%);-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
.bxBBvR:hover{-webkit-text-decoration:underline;text-decoration:underline;cursor:pointer;}/*!sc*/
data-styled.g3[id="sc-acb0869a-0"]{content:"cgZEsQ,bxBBvR,"}/*!sc*/
.gNbimG::before{content:'';display:block;height:150px;margin-top:-150px;visibility:hidden;pointer-events:none;}/*!sc*/
data-styled.g4[id="sc-81445bbc-0"]{content:"gNbimG,"}/*!sc*/
.hIuHOm{width:100%;height:auto;max-width:660px;max-height:433px;}/*!sc*/
.cBLqYz{width:100%;height:auto;max-width:215px;}/*!sc*/
.cBpdBS{width:100%;height:auto;max-width:50px;max-height:50px;}/*!sc*/
data-styled.g5[id="sc-e706b2c9-0"]{content:"hIuHOm,cBLqYz,cBpdBS,"}/*!sc*/
.bmCIia{position:fixed;top:0;left:0;width:100%;height:100%;background-color:hsl(0,0%,0%);opacity:0;pointer-events:none;-webkit-transition:opacity 200ms ease-in-out;transition:opacity 200ms ease-in-out;z-index:1100;}/*!sc*/
data-styled.g8[id="sc-bdc700bb-0"]{content:"bmCIia,"}/*!sc*/
.jeZlQy{position:relative;margin:1.67em 0;width:100%;font-size:0.75em;font-weight:600;line-height:1;text-align:center;z-index:1;}/*!sc*/
.jeZlQy:before{content:'';position:absolute;left:0;right:0;top:50%;-webkit-transform:translateY(-50%);-ms-transform:translateY(-50%);transform:translateY(-50%);border-bottom:1px dashed hsl(0,0%,38%);z-index:-1;}/*!sc*/
data-styled.g9[id="sc-4fbbd49c-0"]{content:"jeZlQy,"}/*!sc*/
.EckBW{padding:0 16px;text-transform:uppercase;background-color:hsl(0,0%,100%);pointer-events:none;}/*!sc*/
data-styled.g10[id="sc-4fbbd49c-1"]{content:"EckBW,"}/*!sc*/
.haeKWy{padding:0.5em 1.5em;text-transform:uppercase;cursor:pointer;-webkit-transition: background-color 300ms ease-in-out, border-color 300ms ease-in-out, box-shadow 300ms ease-in-out;transition: background-color 300ms ease-in-out, border-color 300ms ease-in-out, box-shadow 300ms ease-in-out;}/*!sc*/
.haeKWy:hover,.haeKWy:active,.haeKWy:focus{outline:0;}/*!sc*/
.haeKWy:disabled{box-shadow:none;}/*!sc*/
data-styled.g11[id="sc-c8bbe1ac-0"]{content:"haeKWy,"}/*!sc*/
.OrBVy{color:hsl(0,0%,100%);background-color:hsl(4,68%,52%);border:3px solid hsl(4,68%,52%);font-weight:700;}/*!sc*/
.OrBVy:hover,.OrBVy:active,.OrBVy:focus{box-shadow: 0 0 10px 0px rgba(216,60,49,0.4), 0 0 3px 0px rgba(0,0,0,0.5);}/*!sc*/
.OrBVy:active{background-color:#b42c22;border-color:#b42c22;}/*!sc*/
.OrBVy:disabled{color:hsl(0,0%,94%);background-color:#a76762;border-color:#a76762;}/*!sc*/
data-styled.g13[id="sc-b65b6186-0"]{content:"OrBVy,"}/*!sc*/
.gdbaPI{margin:0px auto 0px;padding:0 32px;width:calc(64rem + 32px);max-width:100%;}/*!sc*/
data-styled.g14[id="sc-87d213a0-0"]{content:"gdbaPI,"}/*!sc*/
.gUBdPx{margin:1em 0;border:0;border-top:1px solid hsl(0,0%,0%);}/*!sc*/
data-styled.g15[id="sc-c49dd42c-0"]{content:"gUBdPx,"}/*!sc*/
.glnGeY{width:10px;-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;padding:0.25em 1em;font-size:1rem;line-height:1;border:1px solid hsl(0,0%,74%);border-right:0;}/*!sc*/
.glnGeY::-webkit-input-placeholder{font-weight:600;text-transform:uppercase;}/*!sc*/
.glnGeY::-moz-placeholder{font-weight:600;text-transform:uppercase;}/*!sc*/
.glnGeY:-ms-input-placeholder{font-weight:600;text-transform:uppercase;}/*!sc*/
.glnGeY::placeholder{font-weight:600;text-transform:uppercase;}/*!sc*/
data-styled.g16[id="sc-335967e1-0"]{content:"glnGeY,"}/*!sc*/
.kHOLMP{display:none;width:0;height:0;}/*!sc*/
data-styled.g18[id="sc-d6b1ce84-0"]{content:"kHOLMP,"}/*!sc*/
.bcBuPb{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:start;-webkit-justify-content:flex-start;-ms-flex-pack:start;justify-content:flex-start;margin:0;padding:0;}/*!sc*/
.bcBuPb > li:not(:last-child){margin-right:1.8em;}/*!sc*/
.dCQrMY{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;margin:0;padding:0;}/*!sc*/
.dCQrMY > li:not(:last-child){margin-right:1.8em;}/*!sc*/
.fPfgyR{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;margin:0;padding:0;}/*!sc*/
.fPfgyR > li:not(:last-child){margin-right:0.6em;}/*!sc*/
.bcBsUH{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:start;-webkit-justify-content:flex-start;-ms-flex-pack:start;justify-content:flex-start;margin:0;padding:0;}/*!sc*/
.bcBsUH > li:not(:last-child){margin-right:0.5em;}/*!sc*/
data-styled.g19[id="sc-685c5c16-0"]{content:"bcBuPb,dCQrMY,fPfgyR,bcBsUH,"}/*!sc*/
.ffSxBo{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}/*!sc*/
@media (min-width:808px){.ffSxBo{display:none;}}/*!sc*/
.kAFiyK{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}/*!sc*/
@media (max-width:808px){.kAFiyK{display:none;}}/*!sc*/
.iYZeLh{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}/*!sc*/
data-styled.g20[id="sc-f80919c6-0"]{content:"ffSxBo,kAFiyK,iYZeLh,"}/*!sc*/
.kvvjnQ{margin:0.55em 0;font-size:0.88em;font-weight:400;}/*!sc*/
@media screen and (min-width:768px){.kvvjnQ{font-size:1em;}}/*!sc*/
@media screen and (min-width:992px){.kvvjnQ{font-size:1.15em;}}/*!sc*/
data-styled.g24[id="sc-44728060-0"]{content:"kvvjnQ,"}/*!sc*/
.kxCvEg{margin:0.33em 0 0;font-size:1.5em;font-family:"Fjalla One",sans-serif;font-weight:400;line-height:1.25;}/*!sc*/
@media screen and (min-width:768px){.kxCvEg{font-size:2.25em;}}/*!sc*/
@media screen and (min-width:992px){.kxCvEg{font-size:3em;}}/*!sc*/
data-styled.g25[id="sc-4868f6b2-0"]{content:"kxCvEg,"}/*!sc*/
.fChjmv{margin:4px 0;text-align:right;-webkit-transition:color 300ms ease-in-out;transition:color 300ms ease-in-out;font-size:0.65rem;font-weight:700;-webkit-letter-spacing:0.05em;-moz-letter-spacing:0.05em;-ms-letter-spacing:0.05em;letter-spacing:0.05em;color:transparent;}/*!sc*/
data-styled.g26[id="sc-92081554-0"]{content:"fChjmv,"}/*!sc*/
.cbcdaX{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;padding:16px;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}/*!sc*/
@media (min-width:808px){.cbcdaX{-webkit-align-items:flex-start;-webkit-box-align:flex-start;-ms-flex-align:flex-start;align-items:flex-start;}}/*!sc*/
data-styled.g35[id="sc-a0a15a8f-0"]{content:"cbcdaX,"}/*!sc*/
.dORPcO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;}/*!sc*/
@media (min-width:808px){.dORPcO{-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;-webkit-align-items:flex-end;-webkit-box-align:flex-end;-ms-flex-align:flex-end;align-items:flex-end;}}/*!sc*/
data-styled.g36[id="sc-a0a15a8f-1"]{content:"dORPcO,"}/*!sc*/
.bPMdAY{font-size:1.125em;text-transform:uppercase;vertical-align:middle;line-height:1;}/*!sc*/
@media (min-width:808px){.bPMdAY{font-size:1.25em;}}/*!sc*/
@media (min-width:992px){.bPMdAY{font-size:1.3em;}}/*!sc*/
data-styled.g37[id="sc-a0a15a8f-2"]{content:"bPMdAY,"}/*!sc*/
.bmSFuJ{text-transform:uppercase;vertical-align:middle;padding-left:5px;line-height:1;}/*!sc*/
data-styled.g38[id="sc-a0a15a8f-3"]{content:"bmSFuJ,"}/*!sc*/
.bgntqP{display:inline-block;padding:1em 1.2em 0.9em;font-weight:700;color:#1a1a1a;line-height:1.1;text-transform:uppercase;-webkit-transition: color 300ms ease-in-out, border 300ms ease-in-out, box-shadow 300ms ease-in-out, padding 450ms ease-in-out;transition: color 300ms ease-in-out, border 300ms ease-in-out, box-shadow 300ms ease-in-out, padding 450ms ease-in-out;border:3px solid hsl(4,68%,52%);}/*!sc*/
.bgntqP:hover,.bgntqP:active,.bgntqP:focus{box-shadow: 0 0 10px 0px rgba(216,60,49,0.4), 0 0 3px 0px rgba(0,0,0,0.5);-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
.bgntqP:active{background-color:rgba(240,182,178,0.4);}/*!sc*/
.cOuSSg{display:inline-block;padding:0.55em 1.2em 0.45em;font-weight:700;color:hsl(0,0%,100%);line-height:1.1;text-transform:uppercase;-webkit-transition: color 300ms ease-in-out, border 300ms ease-in-out, box-shadow 300ms ease-in-out, padding 450ms ease-in-out;transition: color 300ms ease-in-out, border 300ms ease-in-out, box-shadow 300ms ease-in-out, padding 450ms ease-in-out;border:3px solid hsl(0,0%,100%);}/*!sc*/
.cOuSSg:hover,.cOuSSg:active,.cOuSSg:focus{box-shadow: 0 0 10px 0px rgba(216,60,49,0.4), 0 0 3px 0px rgba(0,0,0,0.5);-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
.cOuSSg:active{background-color:rgba(240,182,178,0.4);}/*!sc*/
.iMktqk{display:inline-block;padding:0.55em 1.2em 0.45em;font-weight:700;color:hsl(0,0%,100%);line-height:1.1;text-transform:uppercase;-webkit-transition: color 300ms ease-in-out, border 300ms ease-in-out, box-shadow 300ms ease-in-out, padding 450ms ease-in-out;transition: color 300ms ease-in-out, border 300ms ease-in-out, box-shadow 300ms ease-in-out, padding 450ms ease-in-out;border:3px solid hsl(4,68%,52%);}/*!sc*/
.iMktqk:hover,.iMktqk:active,.iMktqk:focus{box-shadow: 0 0 10px 0px rgba(216,60,49,0.4), 0 0 3px 0px rgba(0,0,0,0.5);-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
.iMktqk:active{background-color:rgba(240,182,178,0.4);}/*!sc*/
.ckUKXg{display:inline-block;padding:0.75em 1.2em 0.65em;font-weight:700;color:hsl(0,0%,100%);line-height:1.1;text-transform:uppercase;-webkit-transition: color 300ms ease-in-out, border 300ms ease-in-out, box-shadow 300ms ease-in-out, padding 450ms ease-in-out;transition: color 300ms ease-in-out, border 300ms ease-in-out, box-shadow 300ms ease-in-out, padding 450ms ease-in-out;border:3px solid hsl(4,68%,52%);}/*!sc*/
.ckUKXg:hover,.ckUKXg:active,.ckUKXg:focus{box-shadow: 0 0 10px 0px rgba(216,60,49,0.4), 0 0 3px 0px rgba(0,0,0,0.5);-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
.ckUKXg:active{background-color:rgba(240,182,178,0.4);}/*!sc*/
data-styled.g40[id="sc-f3730634-0"]{content:"bgntqP,cOuSSg,iMktqk,ckUKXg,"}/*!sc*/
.jFgOBw{padding:4px 8px;color:hsl(0,0%,100%);font-size:15px;font-family:"Nunito Sans",sans-serif;font-weight:700;line-height:1;text-align:center;text-transform:uppercase;background:hsl(4,68%,52%);border-style:solid;border-color:hsl(0,0%,0%);border-width:2px 0 3px;}/*!sc*/
.jFgOBw a{color:hsl(0,0%,100%);position:relative;padding-right:20px;}/*!sc*/
.jFgOBw a:before,.jFgOBw a:after{content:'';position:absolute;display:block;width:6px;height:6px;bottom:7px;right:7px;-webkit-transform:rotate(45deg);-ms-transform:rotate(45deg);transform:rotate(45deg);border:1px solid hsl(0,0%,100%);border-width:2px 2px 0 0;}/*!sc*/
.jFgOBw a:after{right:2px;}/*!sc*/
@media (min-width:808px){.jFgOBw{border-top:0;}}/*!sc*/
data-styled.g41[id="sc-7baaf555-0"]{content:"jFgOBw,"}/*!sc*/
.dAELGB{border-bottom:2px solid hsl(0,0%,46%);-webkit-transition: color 300ms ease-in-out, border-bottom 300ms ease-in-out;transition: color 300ms ease-in-out, border-bottom 300ms ease-in-out;display:inline-block;margin-top:1em;font-size:0.75em;font-weight:700;text-transform:uppercase;color:hsl(0,0%,46%);}/*!sc*/
.dAELGB:hover{color:hsl(0,0%,0%);border-bottom:2px solid hsl(0,0%,0%);-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
data-styled.g42[id="sc-4e016ad2-0"]{content:"dAELGB,"}/*!sc*/
.dkOAOU{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;margin:0.5em auto;max-width:308px;}/*!sc*/
data-styled.g46[id="sc-61d99178-0"]{content:"dkOAOU,"}/*!sc*/
.eSTMOo{margin:0.75em 0 0;font-family:"Martel",serif;font-weight:700;}/*!sc*/
data-styled.g47[id="sc-61d99178-1"]{content:"eSTMOo,"}/*!sc*/
.fuTWQQ{font-style:italic;}/*!sc*/
data-styled.g58[id="sc-2fa50208-0"]{content:"fuTWQQ,"}/*!sc*/
.gguonj{font-weight:700;}/*!sc*/
data-styled.g59[id="sc-73638515-0"]{content:"gguonj,"}/*!sc*/
.bePCqU{margin-top:1.325em;font-size:0.75em;line-height:1.5;}/*!sc*/
data-styled.g60[id="sc-47c53dda-0"]{content:"bePCqU,"}/*!sc*/
.fHxosg > .lazyload-wrapper{max-width:660px;margin:0 auto;}/*!sc*/
.gAMfTf{border-bottom:1px solid hsl(0,0%,74%);}/*!sc*/
.gAMfTf > .lazyload-wrapper{max-width:660px;margin:0 auto;}/*!sc*/
data-styled.g61[id="sc-202ecc93-0"]{content:"fHxosg,gAMfTf,"}/*!sc*/
.dqnBTe{padding:1em 0;line-height:1.25;color:hsl(0,0%,46%);}/*!sc*/
data-styled.g62[id="sc-202ecc93-1"]{content:"dqnBTe,"}/*!sc*/
.bJxiBI{width:auto;position:relative;height:auto;width:100%;display:inline-block;white-space:nowrap;overflow:hidden;vertical-align:top;}/*!sc*/
data-styled.g63[id="sc-6fbfc10d-0"]{content:"bJxiBI,"}/*!sc*/
.bzmMhn{outline:none;width:0%;min-height:1px;margin:0;padding:0;display:inline-block;vertical-align:top;white-space:normal;}/*!sc*/
data-styled.g64[id="sc-c6956122-0"]{content:"bzmMhn,"}/*!sc*/
.gplNqD{position:relative;padding:0px 20px;margin:0px;}/*!sc*/
data-styled.g67[id="sc-53249186-0"]{content:"gplNqD,"}/*!sc*/
.durxKK{-webkit-transform:translateX( 0% );-ms-transform:translateX( 0% );transform:translateX( 0% );-webkit-transition:-webkit-transform 0.6s ease-in-out;-webkit-transition:transform 0.6s ease-in-out;transition:transform 0.6s ease-in-out;}/*!sc*/
data-styled.g68[id="sc-37efb70a-0"]{content:"durxKK,"}/*!sc*/
.ebjPRL{display:inline-block;vertical-align:middle;overflow:hidden;}/*!sc*/
data-styled.g71[id="StyledIconBase-sc-ea9ulj-0"]{content:"ebjPRL,"}/*!sc*/
.fFLeJP{display:inline-block;}/*!sc*/
.fFLeJP svg{color:hsl(0,0%,74%);width:32px;}/*!sc*/
data-styled.g72[id="sc-5145e07e-0"]{content:"fFLeJP,"}/*!sc*/
.jVpYly{display:none;position:absolute;top:50%;-webkit-transform:translateY(-50%);-ms-transform:translateY(-50%);transform:translateY(-50%);left:8px;padding:0;background:transparent;border:0;outline:none;cursor:not-allowed;}/*!sc*/
.gHCgCv{position:absolute;top:50%;-webkit-transform:translateY(-50%);-ms-transform:translateY(-50%);transform:translateY(-50%);right:8px;padding:0;background:transparent;border:0;outline:none;cursor:pointer;}/*!sc*/
data-styled.g73[id="sc-b4fec831-0"]{content:"jVpYly,gHCgCv,"}/*!sc*/
.brMNmo{display:grid;grid-template-columns:repeat(auto-fill,minmax(12.5rem,1fr));grid-gap:1rem;}/*!sc*/
@media (min-width:711px){.brMNmo{grid-template-columns:repeat(auto-fill,minmax(15.5rem,1fr));}}/*!sc*/
data-styled.g77[id="sc-a30dccf3-0"]{content:"brMNmo,"}/*!sc*/
.iatIbm{font-family:"Martel",serif;font-weight:400;font-size:1.5em;}/*!sc*/
data-styled.g84[id="sc-739331d9-0"]{content:"iatIbm,"}/*!sc*/
.jhHupj{font-weight:700;}/*!sc*/
data-styled.g86[id="sc-be2fc1e4-0"]{content:"jhHupj,"}/*!sc*/
.hmYLKc{font-weight:700;}/*!sc*/
.cOwLcG{font-style:italic;}/*!sc*/
.fsjKLm{font-weight:700;font-style:italic;}/*!sc*/
data-styled.g89[id="sc-4df7a8a0-0"]{content:"kkhobw,hmYLKc,cOwLcG,fsjKLm,"}/*!sc*/
.oUyxt{margin-top:8px;}/*!sc*/
data-styled.g93[id="sc-f2c05f19-0"]{content:"oUyxt,"}/*!sc*/
.iqmVao{display:grid;grid-template-columns:1fr;grid-gap:20px;justify-items:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;text-align:center;width:100%;}/*!sc*/
@media (min-width:808px){.iqmVao{grid-template-columns:repeat(2,1fr);}}/*!sc*/
@media (min-width:992px){.iqmVao{grid-template-columns:repeat(4,1fr);}}/*!sc*/
.iqmVao a{color:hsl(0,0%,100%);text-transform:uppercase;}/*!sc*/
data-styled.g94[id="sc-131d9e26-0"]{content:"iqmVao,"}/*!sc*/
.izHfgR{text-align:center;}/*!sc*/
data-styled.g95[id="sc-6832a32a-0"]{content:"izHfgR,"}/*!sc*/
.eFVKFk{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-content:stretch;-ms-flex-line-pack:stretch;align-content:stretch;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;margin:0 0 64px;}/*!sc*/
.eFVKFk a{display:inline-block;max-width:100px;margin-top:32px;-webkit-flex:1 1 50%;-ms-flex:1 1 50%;flex:1 1 50%;}/*!sc*/
.eFVKFk img{border-radius:3px;}/*!sc*/
@media (min-width:430px){.eFVKFk{margin:0 32px 64px;}.eFVKFk a{-webkit-flex-basis:50%;-ms-flex-preferred-size:50%;flex-basis:50%;}}/*!sc*/
@media (min-width:520px){.eFVKFk a{-webkit-flex-basis:33%;-ms-flex-preferred-size:33%;flex-basis:33%;max-width:33%;}}/*!sc*/
@media (min-width:620px){.eFVKFk{margin:0 auto 64px;max-width:500px;}.eFVKFk a{-webkit-flex-basis:auto;-ms-flex-preferred-size:auto;flex-basis:auto;}}/*!sc*/
data-styled.g96[id="sc-6832a32a-1"]{content:"eFVKFk,"}/*!sc*/
.SiWEt{margin-top:32px;padding:16px;font-size:1rem;color:hsl(0,0%,100%);background:hsl(0,0%,0%);}/*!sc*/
@media (min-width:808px){.SiWEt{padding:64px;}}/*!sc*/
data-styled.g97[id="sc-e3de11d5-0"]{content:"SiWEt,"}/*!sc*/
.dIiUhA{position:relative;max-width:1280px;margin:0 auto;padding:64px;border:4px solid hsl(0,0%,100%);}/*!sc*/
.dIiUhA:before{content:'';position:absolute;top:4px;right:4px;bottom:4px;left:4px;border:4px solid hsl(0,0%,100%);pointer-events:none;}/*!sc*/
data-styled.g98[id="sc-e3de11d5-1"]{content:"dIiUhA,"}/*!sc*/
.hJGlvP{padding:16px 16px 64px;font-size:0.75em;text-transform:uppercase;text-align:center;border-bottom:16px solid hsl(4,68%,52%);}/*!sc*/
data-styled.g99[id="sc-e3de11d5-2"]{content:"hJGlvP,"}/*!sc*/
.iwYtAo{display:inline-block;cursor:pointer;}/*!sc*/
.iwYtAo{color:hsl(0,0%,13%);text-transform:uppercase;line-height:1;border-top:0.1em solid transparent;border-bottom:0.1em solid transparent;-webkit-transition: color 300ms ease-in-out, border 300ms ease-in-out;transition: color 300ms ease-in-out, border 300ms ease-in-out;}/*!sc*/
.iwYtAo:hover,.iwYtAo:active,.iwYtAo:focus{-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
.iwYtAo:hover,.iwYtAo:active,.iwYtAo:focus{color:hsl(0,0%,46%);border-bottom-color:hsl(0,0%,46%);}/*!sc*/
.hnlzuM{display:inline-block;cursor:pointer;}/*!sc*/
.hnlzuM > span{color:hsl(0,0%,13%);text-transform:uppercase;line-height:1;border-top:0.1em solid transparent;border-bottom:0.1em solid transparent;-webkit-transition: color 300ms ease-in-out, border 300ms ease-in-out;transition: color 300ms ease-in-out, border 300ms ease-in-out;}/*!sc*/
.hnlzuM:hover,.hnlzuM:active,.hnlzuM:focus{-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
.hnlzuM:hover > span,.hnlzuM:active > span,.hnlzuM:focus > span{color:hsl(0,0%,46%);border-bottom-color:hsl(0,0%,46%);}/*!sc*/
data-styled.g101[id="sc-5cbbf008-0"]{content:"iwYtAo,hnlzuM,"}/*!sc*/
.kCgQEO{display:none;position:relative;top:0;height:55px;padding:1.13em 0;text-align:center;line-height:1;background:hsl(0,0%,100%);border-bottom:3px solid;z-index:50;-webkit-transition:top 450ms cubic-bezier(0.455,0.03,0.515,0.955);transition:top 450ms cubic-bezier(0.455,0.03,0.515,0.955);}/*!sc*/
@media (min-width:808px){.kCgQEO{display:block;}}/*!sc*/
data-styled.g102[id="sc-b1ea1876-0"]{content:"kCgQEO,"}/*!sc*/
.fyduLz > li + li:before{content:'|';display:inline-block;margin-right:0.6em;-webkit-transform:translateY(-1px);-ms-transform:translateY(-1px);transform:translateY(-1px);}/*!sc*/
data-styled.g103[id="sc-b1ea1876-1"]{content:"fyduLz,"}/*!sc*/
.kGyWxr{display:inline-block;text-transform:uppercase;}/*!sc*/
.kGyWxr a{color:hsl(0,0%,46%);border-bottom:2px solid transparent;-webkit-transition: color 400ms ease-in-out, border-bottom-color 400ms ease-in-out;transition: color 400ms ease-in-out, border-bottom-color 400ms ease-in-out;-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
.kGyWxr a:hover,.kGyWxr a:active,.kGyWxr a:focus{color:hsl(0,0%,13%);border-bottom-color:hsl(0,0%,13%);}/*!sc*/
data-styled.g104[id="sc-b1ea1876-2"]{content:"kGyWxr,"}/*!sc*/
.fMXzcs{display:block;position:relative;margin:0 1em;height:100%;cursor:pointer;}/*!sc*/
data-styled.g105[id="sc-f4c5ff7a-0"]{content:"fMXzcs,"}/*!sc*/
.joqyyC{max-width:220px;opacity:1;-webkit-transition: opacity 450ms ease-in-out, max-height 450ms ease-in-out;transition: opacity 450ms ease-in-out, max-height 450ms ease-in-out;}/*!sc*/
.joqyyC img{display:block;max-width:100%;max-height:100%;}/*!sc*/
.jtBFzW{position:absolute;top:50%;right:0;left:0;-webkit-transform:translateY(-50%);-ms-transform:translateY(-50%);transform:translateY(-50%);max-width:220px;opacity:0;-webkit-transition: opacity 450ms ease-in-out, max-height 450ms ease-in-out;transition: opacity 450ms ease-in-out, max-height 450ms ease-in-out;}/*!sc*/
.jtBFzW img{display:block;max-width:100%;max-height:100%;}/*!sc*/
data-styled.g106[id="sc-f4c5ff7a-1"]{content:"joqyyC,jtBFzW,"}/*!sc*/
.eiQbLZ{margin:0;padding:0;width:30px;background-color:transparent;border:0;}/*!sc*/
data-styled.g107[id="sc-26b7b399-0"]{content:"eiQbLZ,"}/*!sc*/
.bfeKHW{font-size:0.75em;font-weight:700;}/*!sc*/
data-styled.g108[id="sc-26b7b399-1"]{content:"bfeKHW,"}/*!sc*/
.ckxTzE{font-size:0.75em;font-weight:700;}/*!sc*/
data-styled.g109[id="sc-64a3e7e-0"]{content:"ckxTzE,"}/*!sc*/
.cuTKaf{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}/*!sc*/
data-styled.g110[id="sc-64a3e7e-1"]{content:"cuTKaf,"}/*!sc*/
.jhKouo{position:relative;height:85px;font-size:1rem;z-index:1000;}/*!sc*/
@media (min-width:808px){.jhKouo{height:141px;}}/*!sc*/
data-styled.g111[id="sc-45df63c3-0"]{content:"jhKouo,"}/*!sc*/
.hgWsmb{position:fixed;top:0;right:0;left:0;}/*!sc*/
data-styled.g112[id="sc-45df63c3-1"]{content:"hgWsmb,"}/*!sc*/
.casDRa{position:relative;display:grid;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;grid-gap:10px;grid-template-columns:1fr auto 1fr;padding:0 32px;height:85px;background:hsl(0,0%,100%);border-bottom:1px solid hsl(0,0%,0%);-webkit-transition:height 450ms cubic-bezier(0.455,0.03,0.515,0.955);transition:height 450ms cubic-bezier(0.455,0.03,0.515,0.955);z-index:100;}/*!sc*/
.casDRa > div:last-child{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;}/*!sc*/
data-styled.g113[id="sc-45df63c3-2"]{content:"casDRa,"}/*!sc*/
.eCfiVt{font-size:0.85rem;font-weight:700;-webkit-letter-spacing:0.05em;-moz-letter-spacing:0.05em;-ms-letter-spacing:0.05em;letter-spacing:0.05em;}/*!sc*/
data-styled.g139[id="sc-3ef8760c-0"]{content:"eCfiVt,"}/*!sc*/
.dnIUZI{color:inherit;-webkit-text-decoration:underline;text-decoration:underline;font-weight:700;-webkit-transition:opacity 200ms ease-in-out;transition:opacity 200ms ease-in-out;}/*!sc*/
.dnIUZI:hover{opacity:0.75;}/*!sc*/
data-styled.g140[id="sc-3ef8760c-1"]{content:"dnIUZI,"}/*!sc*/
.gdFmEX{margin:0;line-height:1.5;}/*!sc*/
data-styled.g141[id="sc-3ef8760c-2"]{content:"gdFmEX,"}/*!sc*/
.kRJNMy{display:none;}/*!sc*/
@media (min-width:992px){.kRJNMy{display:grid;max-width:1200px;min-height:6.25em;margin:0.5em auto;padding:0 2em;-webkit-column-gap:1em;column-gap:1em;row-gap:0.5em;grid-template-columns:auto 2fr auto auto;grid-template-areas:'left midleft midright right';place-items:center;}}/*!sc*/
data-styled.g142[id="sc-e64f09bb-0"]{content:"kRJNMy,"}/*!sc*/
.hNEEqm{grid-area:left;justify-self:right;text-align:right;font-size:1.5em;font-weight:700;}/*!sc*/
data-styled.g143[id="sc-e64f09bb-1"]{content:"hNEEqm,"}/*!sc*/
.eZzrtd{grid-area:midleft;text-align:left;line-height:1.5;font-size:0.9em;font-weight:700;}/*!sc*/
data-styled.g144[id="sc-e64f09bb-2"]{content:"eZzrtd,"}/*!sc*/
.NnTsm{grid-area:midright;justify-self:left;}/*!sc*/
data-styled.g145[id="sc-e64f09bb-3"]{content:"NnTsm,"}/*!sc*/
.kLscOL{grid-area:right;}/*!sc*/
data-styled.g146[id="sc-e64f09bb-4"]{content:"kLscOL,"}/*!sc*/
.gzwArZ{background:hsl(0,0%,0%);max-height:0;-webkit-transition:max-height 300ms ease-in-out;transition:max-height 300ms ease-in-out;overflow:hidden;text-align:center;}/*!sc*/
data-styled.g147[id="sc-24a7fbea-0"]{content:"gzwArZ,"}/*!sc*/
.hGxOas{padding:1em;}/*!sc*/
data-styled.g148[id="sc-24a7fbea-1"]{content:"hGxOas,"}/*!sc*/
.jqQDPZ{margin-top:0.75em;font-size:1.5em;font-weight:700;}/*!sc*/
data-styled.g149[id="sc-24a7fbea-2"]{content:"jqQDPZ,"}/*!sc*/
.FJGVX{font-size:0.85em;font-weight:600;-webkit-letter-spacing:0.05em;-moz-letter-spacing:0.05em;-ms-letter-spacing:0.05em;letter-spacing:0.05em;color:hsl(46,71%,58%);}/*!sc*/
data-styled.g150[id="sc-24a7fbea-3"]{content:"FJGVX,"}/*!sc*/
@media (min-width:992px){.bntQfD{display:none;}}/*!sc*/
data-styled.g151[id="sc-a2aa4e38-0"]{content:"bntQfD,"}/*!sc*/
.jcjUUT{text-align:center;padding:2.4em 0.5em;}/*!sc*/
data-styled.g152[id="sc-a2aa4e38-1"]{content:"jcjUUT,"}/*!sc*/
.fYazMM{display:inline-block;margin-right:0.75em;font-size:1.1em;font-weight:700;}/*!sc*/
data-styled.g153[id="sc-a2aa4e38-2"]{content:"fYazMM,"}/*!sc*/
.dhwHRZ{background:transparent;border:0;outline:0;color:hsl(0,0%,100%);}/*!sc*/
data-styled.g154[id="sc-a2aa4e38-3"]{content:"dhwHRZ,"}/*!sc*/
.fIkXwQ{position:fixed;right:0;bottom:0;left:0;text-transform:uppercase;color:hsl(0,0%,100%);background:hsl(4,68%,52%);box-shadow:0px -2px 04px 0px rgba(0,0,0,0.3);z-index:1000;}/*!sc*/
data-styled.g155[id="sc-aeb3ddd8-0"]{content:"fIkXwQ,"}/*!sc*/
.fmhyDa{margin-bottom:4em;}/*!sc*/
data-styled.g162[id="sc-a7a77854-1"]{content:"fmhyDa,"}/*!sc*/
.hYUFsa{display:block;margin:16px auto 0;padding:16px 0;width:142px;font-size:0.75em;font-weight:700;-webkit-letter-spacing:0.1em;-moz-letter-spacing:0.1em;-ms-letter-spacing:0.1em;letter-spacing:0.1em;text-transform:uppercase;color:hsl(0,0%,0%);background-color:hsl(46,71%,58%);text-align:center;-webkit-transition:box-shadow 350ms ease-in-out;transition:box-shadow 350ms ease-in-out;}/*!sc*/
.hYUFsa:hover,.hYUFsa:active,.hYUFsa:focus{-webkit-text-decoration:none;text-decoration:none;box-shadow:0 0 8px 0px rgba(0,0,0,0.2);}/*!sc*/
data-styled.g163[id="sc-a7a77854-2"]{content:"hYUFsa,"}/*!sc*/
.kFFBpt{line-height:24px;}/*!sc*/
data-styled.g182[id="sc-426c7a0c-0"]{content:"kFFBpt,"}/*!sc*/
.duTNrl{margin:2.5em 0;text-align:center;}/*!sc*/
data-styled.g183[id="sc-342deb74-0"]{content:"duTNrl,"}/*!sc*/
.kZLSoz{padding-top:1.2em;font-size:0.9em;}/*!sc*/
data-styled.g184[id="sc-342deb74-1"]{content:"kZLSoz,"}/*!sc*/
.gecSKd{padding:16px;text-align:right;}/*!sc*/
data-styled.g185[id="sc-93418c49-0"]{content:"gecSKd,"}/*!sc*/
.lbrRCn{padding:0;width:24px;color:hsl(0,0%,100%);background:transparent;border:0;cursor:pointer;}/*!sc*/
data-styled.g186[id="sc-93418c49-1"]{content:"lbrRCn,"}/*!sc*/
.fLfSeK{padding:0.5em 0;border-top:1px solid rgba(255,255,255,0.25);}/*!sc*/
.fLfSeK:last-child{border-bottom:1px solid rgba(255,255,255,0.25);}/*!sc*/
.fLfSeK > a{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;color:hsl(0,0%,100%);text-transform:uppercase;-webkit-text-decoration:none;text-decoration:none;}/*!sc*/
data-styled.g187[id="sc-16326799-0"]{content:"fLfSeK,"}/*!sc*/
.edRbLk{display:inline-block;-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;}/*!sc*/
data-styled.g188[id="sc-16326799-1"]{content:"edRbLk,"}/*!sc*/
.gDzKSJ{display:inline-block;width:24px;}/*!sc*/
data-styled.g189[id="sc-16326799-2"]{content:"gDzKSJ,"}/*!sc*/
.bppzWr{margin:0 1em;padding:0;list-style:none;}/*!sc*/
data-styled.g190[id="sc-5ef19ac2-0"]{content:"bppzWr,"}/*!sc*/
.kYxrvQ{position:fixed;top:0;right:0;bottom:0;left:0;font-size:1rem;pointer-events:none;z-index:1300;}/*!sc*/
data-styled.g191[id="sc-c114e581-0"]{content:"kYxrvQ,"}/*!sc*/
.jXVATq{position:absolute;top:0;bottom:0;left:-262px;width:262px;background-color:hsl(0,0%,0%);color:hsl(0,0%,100%);overflow-y:auto;-webkit-transition:left 200ms ease-in-out;transition:left 200ms ease-in-out;pointer-events:auto;}/*!sc*/
@media (min-width:576px){.jXVATq{left:-350px;width:350px;}}/*!sc*/
data-styled.g192[id="sc-c114e581-1"]{content:"jXVATq,"}/*!sc*/
.bkOpQU{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin:16px 0;padding:0 16px;height:32px;background:repeating-linear-gradient(-45deg,rgba(0,0,0,0) 0px,#bdbdbd 1px,#bdbdbd 1px,rgba(0,0,0,0) 2px,rgba(0,0,0,0) 3px);}/*!sc*/
data-styled.g193[id="sc-ea6cad81-0"]{content:"bkOpQU,"}/*!sc*/
.dtcmRn{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:16px;text-transform:uppercase;background:hsl(0,0%,100%);}/*!sc*/
data-styled.g194[id="sc-ea6cad81-1"]{content:"dtcmRn,"}/*!sc*/
.dEvxDw{border-top:3px solid hsl(0,0%,0%);border-bottom:8px solid hsl(0,0%,0%);}/*!sc*/
data-styled.g195[id="sc-bb8c2e70-0"]{content:"dEvxDw,"}/*!sc*/
.gaMYLq{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;}/*!sc*/
@media (min-width:768px){.gaMYLq{margin-bottom:16px;}}/*!sc*/
data-styled.g196[id="sc-bb8c2e70-1"]{content:"gaMYLq,"}/*!sc*/
.iOtZCv{display:grid;grid-template-rows:repeat(2,1fr);min-height:300px;margin-left:8px;margin-right:8px;-webkit-box-pack:stretch;-webkit-justify-content:stretch;-ms-flex-pack:stretch;justify-content:stretch;width:100%;}/*!sc*/
.iOtZCv > *:not(:last-child){border-bottom:2px solid hsl(0,0%,0%);margin-bottom:8px;}/*!sc*/
@media (min-width:768px){.iOtZCv > *:not(:last-child){border-bottom:0;margin-bottom:0;border-right:2px solid hsl(0,0%,94%);margin-right:8px;}}/*!sc*/
@media (min-width:768px){.iOtZCv{grid-template-rows:none;grid-template-columns:repeat(2,1fr);max-width:1200px;min-height:auto;max-height:250px;}}/*!sc*/
data-styled.g197[id="sc-bb8c2e70-2"]{content:"iOtZCv,"}/*!sc*/
.eztMZN{width:100%;font-size:0.75em;}/*!sc*/
data-styled.g205[id="sc-dd7abf72-0"]{content:"eztMZN,"}/*!sc*/
.eifopM{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;height:auto;width:100%;}/*!sc*/
data-styled.g206[id="sc-dd7abf72-1"]{content:"eifopM,"}/*!sc*/
.fwcCIP{margin:16px 0;}/*!sc*/
data-styled.g207[id="sc-539cc9d9-0"]{content:"fwcCIP,"}/*!sc*/
.hGVYrY{width:100%;text-align:center;margin:16px;}/*!sc*/
@media (min-width:372px){.hGVYrY{text-align:right;padding-right:16px;}}/*!sc*/
data-styled.g208[id="sc-539cc9d9-1"]{content:"hGVYrY,"}/*!sc*/
.bJeNAn{-webkit-flex:1 1 auto;-ms-flex:1 1 auto;flex:1 1 auto;margin:0 auto;padding:16px;max-width:256px;}/*!sc*/
data-styled.g209[id="sc-8eaa343d-0"]{content:"bJeNAn,"}/*!sc*/
.gcujOa{display:block;width:100%;text-align:center;}/*!sc*/
data-styled.g210[id="sc-8eaa343d-1"]{content:"gcujOa,"}/*!sc*/
.ixbrMF{margin:16px 0;border:1px solid hsl(0,0%,84%);}/*!sc*/
data-styled.g211[id="sc-8eaa343d-2"]{content:"ixbrMF,"}/*!sc*/
.djqOxY{color:hsl(0,0%,46%);font-size:0.625em;font-weight:700;-webkit-letter-spacing:0.1em;-moz-letter-spacing:0.1em;-ms-letter-spacing:0.1em;letter-spacing:0.1em;text-transform:uppercase;}/*!sc*/
data-styled.g212[id="sc-8eaa343d-3"]{content:"djqOxY,"}/*!sc*/
.kaFnJo{display:block;margin-top:8px;color:hsl(0,0%,13%);font-family:"Martel",serif;font-weight:700;line-height:1.25;}/*!sc*/
data-styled.g213[id="sc-8eaa343d-4"]{content:"kaFnJo,"}/*!sc*/
.ernAPE{margin:16px 0;}/*!sc*/
data-styled.g219[id="sc-8c045442-0"]{content:"ernAPE,"}/*!sc*/
.XCZAi{color:hsl(4,68%,52%);font-weight:bold;}/*!sc*/
data-styled.g220[id="sc-8c045442-1"]{content:"XCZAi,"}/*!sc*/
.kBtZqG{margin:0 auto;}/*!sc*/
data-styled.g221[id="sc-8c045442-2"]{content:"kBtZqG,"}/*!sc*/
.NNFyi{font-size:0.75em;}/*!sc*/
data-styled.g222[id="sc-8c045442-3"]{content:"NNFyi,"}/*!sc*/
.cSQUFG{display:inline-block;margin:0 0.5em 0.5em 0;padding:0.25em 0.5em;font-weight:600;text-transform:lowercase;background:hsl(0,0%,94%);}/*!sc*/
.cSQUFG > a{color:hsl(0,0%,13%);}/*!sc*/
data-styled.g223[id="sc-de217756-0"]{content:"cSQUFG,"}/*!sc*/
.hULpA-D{margin:2em 0 0;padding:0;}/*!sc*/
data-styled.g224[id="sc-fc31822f-0"]{content:"hULpA-D,"}/*!sc*/
.dzIqeJ{margin-top:1.25em;font-weight:700;}/*!sc*/
data-styled.g227[id="sc-200b33bd-0"]{content:"dzIqeJ,"}/*!sc*/
.gZTjVm{display:inline-block;margin-top:1.6em;padding:0.9em 1.1em 0.8em;font-size:0.625em;font-weight:700;-webkit-letter-spacing:0.1em;-moz-letter-spacing:0.1em;-ms-letter-spacing:0.1em;letter-spacing:0.1em;line-height:1;text-transform:uppercase;color:hsl(0,0%,100%);background-color:hsl(204,70%,42%);}/*!sc*/
data-styled.g228[id="sc-36739995-0"]{content:"gZTjVm,"}/*!sc*/
.ersxds{display:inline-block;margin-top:1em;}/*!sc*/
data-styled.g229[id="sc-f4d70fa7-0"]{content:"ersxds,"}/*!sc*/
.llLGAK{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;margin-bottom:40px;}/*!sc*/
.llLGAK > button + button{margin-left:8px;}/*!sc*/
data-styled.g246[id="sc-5fc35b96-0"]{content:"llLGAK,"}/*!sc*/
.kGGzyr{-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;-webkit-flex-shrink:1;-ms-flex-negative:1;flex-shrink:1;max-width:100%;}/*!sc*/
data-styled.g251[id="sc-4abb9ce9-0"]{content:"kGGzyr,"}/*!sc*/
.dJAeue{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:1em 0;border-top:1em solid hsl(0,0%,26%);border-bottom:1px solid hsl(0,0%,74%);}/*!sc*/
@media (min-width:590px){.dJAeue{-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;}}/*!sc*/
data-styled.g253[id="sc-2dbade60-0"]{content:"dJAeue,"}/*!sc*/
.ivnhTC{margin:0 0 1em 0;}/*!sc*/
@media (min-width:590px){.ivnhTC{margin:0 4em 0 0;}}/*!sc*/
data-styled.g254[id="sc-2dbade60-1"]{content:"ivnhTC,"}/*!sc*/
.cdTYpC{margin:0;font-family:"Fjalla One",sans-serif;font-weight:400;}/*!sc*/
data-styled.g255[id="sc-2dbade60-2"]{content:"cdTYpC,"}/*!sc*/
.deMHqo{font-size:0.75em;margin-top:0.34em;}/*!sc*/
data-styled.g256[id="sc-2dbade60-3"]{content:"deMHqo,"}/*!sc*/
.gnCDei::after{content:'';display:block;margin:1em 0 2em;width:2em;border-bottom:5px double hsl(0,0%,0%);}/*!sc*/
data-styled.g260[id="sc-4b98f9c7-0"]{content:"gnCDei,"}/*!sc*/
</style><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Martel:wght@400;600;700&family=Nunito+Sans:wght@400;600;700&family=Fjalla+One:wght@400;500&display=swap"/></head><body><div id="__next"><div class="sc-45df63c3-0 jhKouo"><div class="sc-45df63c3-1 hgWsmb"><div class="sc-45df63c3-2 casDRa"><div><ul class="sc-685c5c16-0 sc-26b7b399-1 bcBuPb bfeKHW"><li class="sc-f80919c6-0 ffSxBo"><button class="sc-26b7b399-0 eiQbLZ"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M3 18h18v-2H3v2zm0-5h18v-2H3v2zm0-7v2h18V6H3z"></path></svg></button></li><li class="sc-f80919c6-0 kAFiyK"><a href="/magazine" class="sc-5cbbf008-0 iwYtAo">The Magazine</a></li><li class="sc-f80919c6-0 kAFiyK"><a href="https://myscienceshop.com/?utm_source=discovermag&amp;utm_medium=website&amp;utm_campaign=site_header" class="sc-5cbbf008-0 iwYtAo">Shop</a></li></ul></div><div><a href="/" class="sc-f4c5ff7a-0 fMXzcs"><div class="sc-f4c5ff7a-1 joqyyC"><div class="lazyload-wrapper "><div style="height:64px" class="lazyload-placeholder"></div></div></div><div class="sc-f4c5ff7a-1 jtBFzW"><div class="lazyload-wrapper "><div style="height:14px" class="lazyload-placeholder"></div></div></div></a></div><div><ul class="sc-685c5c16-0 sc-64a3e7e-0 dCQrMY ckxTzE"><li class="sc-f80919c6-0 kAFiyK"><a class="sc-5cbbf008-0 iwYtAo">Login</a></li><li class="sc-f80919c6-0 kAFiyK"><a class="sc-5cbbf008-0 iwYtAo">Register</a></li><li class="sc-f80919c6-0 kAFiyK"><a href="/newsletter-signup" class="sc-5cbbf008-0 sc-64a3e7e-1 hnlzuM cuTKaf"><svg viewBox="0 0 24 24" height="24" width="24" aria-hidden="true" focusable="false" fill="hsl(0, 0%, 100%)" xmlns="http://www.w3.org/2000/svg" stroke="hsl(4, 68%, 52%)" style="margin-right:4px;margin-top:1px;flex-shrink:0" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M20 4H4c-1.1 0-1.99.9-1.99 2L2 18c0 1.1.9 2 2 2h16c1.1 0 2-.9 2-2V6c0-1.1-.9-2-2-2zm0 4-8 5-8-5V6l8 5 8-5v2z"></path></svg><span>Stay Curious</span></a></li><li class="sc-f80919c6-0 iYZeLh"><a href="https://kalmbach.dragonforms.com/loading.do?omedasite=DSS_New&amp;pk=DSF43D1" class="sc-acb0869a-0 cgZEsQ sc-f3730634-0 bgntqP" target="_blank" rel="noopener">Subscribe</a></li></ul></div></div><div class="sc-b1ea1876-0 kCgQEO"><ul class="sc-685c5c16-0 sc-b1ea1876-1 fPfgyR fyduLz"><li class="sc-b1ea1876-2 kGyWxr"><a href="/the-sciences" class="sc-5cbbf008-0 iwYtAo">The Sciences</a></li><li class="sc-b1ea1876-2 kGyWxr"><a href="/mind" class="sc-5cbbf008-0 iwYtAo">Mind</a></li><li class="sc-b1ea1876-2 kGyWxr"><a href="/technology" class="sc-5cbbf008-0 iwYtAo">Technology</a></li><li class="sc-b1ea1876-2 kGyWxr"><a href="/health" class="sc-5cbbf008-0 iwYtAo">Health</a></li><li class="sc-b1ea1876-2 kGyWxr"><a href="/environment" class="sc-5cbbf008-0 iwYtAo">Environment</a></li><li class="sc-b1ea1876-2 kGyWxr"><a href="/planet-earth" class="sc-5cbbf008-0 iwYtAo">Planet Earth</a></li></ul></div></div></div><div class="sc-7baaf555-0 jFgOBw"><span><a href="https://www.discovermagazine.com/maintenance">We have completed maintenance on DiscoverMagazine.com and action may be required on your account. Learn More</a></span></div><div class="sc-87d213a0-0 sc-4b98f9c7-0 gdbaPI gnCDei"><div id="articlePageTopMobile"></div><ul class="sc-685c5c16-0 bcBsUH"><li class="sc-f80919c6-0 iYZeLh"><a class="sc-acb0869a-0 cgZEsQ sc-f4d70fa7-0 ersxds" href="https://www.discovermagazine.com"><svg viewBox="0 0 24 24" height="24" width="24" aria-hidden="true" focusable="false" fill="hsl(0, 0%, 100%)" xmlns="http://www.w3.org/2000/svg" stroke="hsl(4, 68%, 52%)" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M10 20v-6h4v6h5v-8h3L12 3 2 12h3v8z"></path></svg></a></li><li class="sc-f80919c6-0 iYZeLh"><div class="sc-200b33bd-0 dzIqeJ">/</div></li><li class="sc-f80919c6-0 iYZeLh"><div><a class="sc-acb0869a-0 cgZEsQ sc-36739995-0 gZTjVm" href="/health">Health</a></div></li></ul><h1 class="sc-4868f6b2-0 kxCvEg">What’s Next In The Ozempic Era?</h1><h2 class="sc-44728060-0 kvvjnQ">Diabetes, weight loss and now heart health: A new family of drugs is changing the way scientists are thinking about obesity — and more uses are on the horizon</h2><div class="sc-47c53dda-0 bePCqU"><div><span class="sc-2fa50208-0 fuTWQQ">By <a class="sc-acb0869a-0 cgZEsQ" href="/author/matias-a-loewy-knowable-magazine">Matías A. Loewy, Knowable Magazine</a></span></div><div><span class="sc-73638515-0 gguonj">Apr 25, 2024 7:00 PM</span></div></div></div><div class="sc-87d213a0-0 gdbaPI"><div style="display:flex"><div class="sc-4abb9ce9-0 kGGzyr"><div class="sc-5fc35b96-0 llLGAK"><button class="react-share__ShareButton" style="background-color:transparent;border:none;padding:0;font:inherit;color:inherit;cursor:pointer"><svg viewBox="0 0 64 64" width="32" height="32"><rect width="64" height="64" rx="0" ry="0" fill="#0965FE"></rect><path d="M34.1,47V33.3h4.6l0.7-5.3h-5.3v-3.4c0-1.5,0.4-2.6,2.6-2.6l2.8,0v-4.8c-0.5-0.1-2.2-0.2-4.1-0.2 c-4.1,0-6.9,2.5-6.9,7V28H24v5.3h4.6V47H34.1z" fill="white"></path></svg></button><button class="react-share__ShareButton" style="background-color:transparent;border:none;padding:0;font:inherit;color:inherit;cursor:pointer"><svg viewBox="0 0 64 64" width="32" height="32"><rect width="64" height="64" rx="0" ry="0" fill="#000000"></rect><path d="M 41.116 18.375 h 4.962 l -10.8405 12.39 l 12.753 16.86 H 38.005 l -7.821 -10.2255 L 21.235 47.625 H 16.27 l 11.595 -13.2525 L 15.631 18.375 H 25.87 l 7.0695 9.3465 z m -1.7415 26.28 h 2.7495 L 24.376 21.189 H 21.4255 z" fill="white"></path></svg></button><button class="react-share__ShareButton" style="background-color:transparent;border:none;padding:0;font:inherit;color:inherit;cursor:pointer"><svg viewBox="0 0 64 64" width="32" height="32"><rect width="64" height="64" rx="0" ry="0" fill="#FF5700"></rect><path d="M 53.34375 32 C 53.277344 30.160156 52.136719 28.53125 50.429688 27.839844 C 48.722656 27.148438 46.769531 27.523438 45.441406 28.800781 C 41.800781 26.324219 37.519531 24.957031 33.121094 24.863281 L 35.199219 14.878906 L 42.046875 16.320312 C 42.214844 17.882812 43.496094 19.09375 45.066406 19.171875 C 46.636719 19.253906 48.03125 18.183594 48.359375 16.644531 C 48.6875 15.105469 47.847656 13.558594 46.382812 12.992188 C 44.914062 12.425781 43.253906 13.007812 42.464844 14.367188 L 34.625 12.800781 C 34.363281 12.742188 34.09375 12.792969 33.871094 12.9375 C 33.648438 13.082031 33.492188 13.308594 33.441406 13.566406 L 31.070312 24.671875 C 26.617188 24.738281 22.277344 26.105469 18.59375 28.609375 C 17.242188 27.339844 15.273438 26.988281 13.570312 27.707031 C 11.863281 28.429688 10.746094 30.089844 10.71875 31.941406 C 10.691406 33.789062 11.757812 35.484375 13.441406 36.257812 C 13.402344 36.726562 13.402344 37.195312 13.441406 37.664062 C 13.441406 44.832031 21.792969 50.65625 32.097656 50.65625 C 42.398438 50.65625 50.753906 44.832031 50.753906 37.664062 C 50.789062 37.195312 50.789062 36.726562 50.753906 36.257812 C 52.363281 35.453125 53.371094 33.800781 53.34375 32 Z M 21.34375 35.199219 C 21.34375 33.433594 22.777344 32 24.542969 32 C 26.3125 32 27.742188 33.433594 27.742188 35.199219 C 27.742188 36.96875 26.3125 38.398438 24.542969 38.398438 C 22.777344 38.398438 21.34375 36.96875 21.34375 35.199219 Z M 39.9375 44 C 37.664062 45.710938 34.871094 46.582031 32.03125 46.464844 C 29.191406 46.582031 26.398438 45.710938 24.128906 44 C 23.847656 43.65625 23.871094 43.15625 24.183594 42.839844 C 24.5 42.527344 25 42.503906 25.34375 42.785156 C 27.269531 44.195312 29.617188 44.90625 32 44.800781 C 34.386719 44.929688 36.746094 44.242188 38.6875 42.847656 C 39.042969 42.503906 39.605469 42.511719 39.953125 42.863281 C 40.296875 43.21875 40.289062 43.785156 39.9375 44.128906 Z M 39.359375 38.527344 C 37.59375 38.527344 36.160156 37.09375 36.160156 35.328125 C 36.160156 33.5625 37.59375 32.128906 39.359375 32.128906 C 41.128906 32.128906 42.558594 33.5625 42.558594 35.328125 C 42.59375 36.203125 42.269531 37.054688 41.65625 37.6875 C 41.046875 38.316406 40.203125 38.664062 39.328125 38.65625 Z M 39.359375 38.527344" fill="white"></path></svg></button><button class="react-share__ShareButton" style="background-color:transparent;border:none;padding:0;font:inherit;color:inherit;cursor:pointer"><svg viewBox="0 0 64 64" width="32" height="32"><rect width="64" height="64" rx="0" ry="0" fill="#EF3F56"></rect><path d="M41.084 29.065l-7.528 7.882a2.104 2.104 0 0 1-1.521.666 2.106 2.106 0 0 1-1.522-.666l-7.528-7.882c-.876-.914-.902-2.43-.065-3.384.84-.955 2.228-.987 3.1-.072l6.015 6.286 6.022-6.286c.88-.918 2.263-.883 3.102.071.841.938.82 2.465-.06 3.383l-.015.002zm6.777-10.976C47.463 16.84 46.361 16 45.14 16H18.905c-1.2 0-2.289.82-2.716 2.044-.125.363-.189.743-.189 1.125v10.539l.112 2.096c.464 4.766 2.73 8.933 6.243 11.838.06.053.125.102.19.153l.04.033c1.882 1.499 3.986 2.514 6.259 3.014a14.662 14.662 0 0 0 6.13.052c.118-.042.235-.065.353-.087.03 0 .065-.022.098-.042a15.395 15.395 0 0 0 6.011-2.945l.039-.045.18-.153c3.502-2.902 5.765-7.072 6.248-11.852L48 29.674v-10.52c0-.366-.041-.728-.161-1.08l.022.015z" fill="white"></path></svg></button><button class="react-share__ShareButton" style="background-color:transparent;border:none;padding:0;font:inherit;color:inherit;cursor:pointer"><svg viewBox="0 0 64 64" width="32" height="32"><rect width="64" height="64" rx="0" ry="0" fill="#7f7f7f"></rect><path d="M17,22v20h30V22H17z M41.1,25L32,32.1L22.9,25H41.1z M20,39V26.6l12,9.3l12-9.3V39H20z" fill="white"></path></svg></button></div><div class="sc-202ecc93-0 fHxosg"><img src="//images.ctfassets.net/cnu0m8re1exe/64FrvaM7dXAkdp1SirxJMG/fb905076e6fb05b3e4f3892b6be0e369/ozempic-8282315_1280.jpg?fm=jpg&amp;fl=progressive&amp;w=660&amp;h=433&amp;fit=fill" alt="ozempic-8282315 1280" height="660px" width="433px" class="sc-e706b2c9-0 hIuHOm"/><div class="sc-202ecc93-1 dqnBTe">Image by Markus Winkler from Pixabay</div></div><section class="sc-2dbade60-0 dJAeue"><div class="sc-2dbade60-1 ivnhTC"><h2 class="sc-2dbade60-2 cdTYpC">Newsletter</h2><div class="sc-2dbade60-3 deMHqo">Sign up for our email newsletter for the latest science news</div></div><form class="sc-dd7abf72-0 eztMZN"><div class="sc-dd7abf72-1 eifopM"><input aria-label="Email Address" autoComplete="email" placeholder="Email Address" class="sc-335967e1-0 glnGeY"/><button aria-label="Sign Up for Newsletter" type="submit" color="hsl(4, 68%, 52%)" class="sc-c8bbe1ac-0 sc-b65b6186-0 haeKWy OrBVy">Sign Up</button></div><div class="sc-92081554-0 fChjmv"> </div></form></section><div class="instaread-audio-player" style="margin-top:1em"><iframe allow="autoplay; clipboard-write; encrypted-media; fullscreen; picture-in-picture" allowfullscreen="" id="instaread_iframe" loading="lazy" name="instaread_playlist" sandbox="allow-same-origin allow-scripts allow-popups allow-forms allow-modals" title="Audio Article" class="sc-d6b1ce84-0 kHOLMP"></iframe></div><article class="sc-426c7a0c-0 kFFBpt"><p><span class="sc-4df7a8a0-0 kkhobw">Few drugs have achieved the stardom that semaglutide, marketed in the United States as Ozempic or Wegovy, has today. A synthetic, injectable version of an intestinal hormone, it is the flagship of a new category of drugs initially developed for diabetes that rose to fame in the medical and public arena as an effective weapon against obesity. Semaglutide has proved so successful that its manufacturer, the Danish company Novo Nordisk, is unable to keep up with demand.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">The US Food and Drug Administration approved semaglutide in 2017 to improve the control of blood sugar levels in adults with type 2 diabetes — and then, in June 2021, </span><a href="https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">for chronic weight management in adults who are obese or overweight</span></a><span class="sc-4df7a8a0-0 kkhobw"> and have related risk factors, such as high blood pressure or diabetes.</span></p><p><span class="sc-4df7a8a0-0 kkhobw"></span><a href="https://mashable.com/article/wegovy-ozempic-kim-kardashian-weight-loss" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">Social networks boosted the drug’s fame</span></a><span class="sc-4df7a8a0-0 kkhobw">: In mid-2022, a viral TikTok clip claimed Kim Kardashian had used semaglutide to lose 15 pounds so that she could wear an iconic Marilyn Monroe dress to the Met Gala in New York. In the months that followed, everyone from former British Prime Minister Boris Johnson to billionaire entrepreneur Elon Musk acknowledged resorting to the medication to tamp down their appetites and slim down. Today, </span><a href="https://www.pewresearch.org/science/2024/02/26/how-americans-view-weight-loss-drugs-and-their-potential-impact-on-obesity-in-the-u-s/" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">three out of four Americans say they have heard of this type of drug</span></a><span class="sc-4df7a8a0-0 kkhobw"> — and of those, more than half consider it a good option for weight loss, according to a Pew Research survey.</span></p><div id="insticator-container" class="embedid-9b6b7608-0101-4c26-8de9-6aad26a6d2b9"><div id="div-insticator-ad-1"></div><div id="insticator-embed"></div><div id="div-insticator-ad-2"></div></div><p><span class="sc-4df7a8a0-0 kkhobw">Last November, however, the ones with their eyes on the drug were cardiologists. At the opening of the 2023 annual meeting of the American Heart Association in Philadelphia, results of a clinical trial generated tremendous interest: Semaglutide, it appeared, was a new tool to treat heart disease.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">The trial, </span><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2307563" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">called SELECT, was conducted in 41 countries with more than 17,000</span></a><span class="sc-4df7a8a0-0 kkhobw"> people who were overweight or obese and at high cardiovascular risk but who didn’t have diabetes. It found that a weekly subcutaneous injection of 2.4 milligrams of semaglutide can, in addition to helping people lose an average of 15 percent of their original weight, reduce the risk of heart attack, stroke or death by 20 percent. It’s a magnitude of effect that puts it in the same category as other drugs that prevent cardiovascular events, such as low-dose aspirin, antihypertensives and statins to lower </span><a href="https://knowablemagazine.org/content/article/health-disease/2024/cholesterol-and-heart-disease-explained" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">cholesterol</span></a><span class="sc-4df7a8a0-0 kkhobw">.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">From the study, scientists could calculate the total number of people who would need to be treated to produce the desired benefit in one of them. They found that treating 67 diabetes-free overweight or obese patients at high risk of a cardiovascular event for 40 months would prevent one major cardiovascular event, such as heart attack or stroke, or death due to heart disease. By way of comparison, this is the same number of patients with a cardiovascular history who must take </span><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838845/" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">aspirin</span></a><span class="sc-4df7a8a0-0 kkhobw"> or </span><a href="https://thennt.com/nnt/anti-hypertensives-to-prevent-death-heart-attacks-and-strokes/" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">hypertension drugs</span></a><span class="sc-4df7a8a0-0 kkhobw"> for 60 months to avoid one stroke.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Based on the study results, in early March </span><a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">the FDA approved the use of injectable semaglutide to reduce the risk of cardiovascular death</span></a><span class="sc-4df7a8a0-0 kkhobw">, myocardial infarction and stroke in adults with cardiovascular disease who are obese or overweight.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">“It’s a milestone. For the first time, we have a drug, semaglutide, that not only causes weight loss, but also reduces the formation of atherosclerotic plaque and prevents deaths and cardiovascular events,” says Paola Harwicz, a cardiologist and obesity specialist in Buenos Aires who headed the Cardiometabolism Council of the Argentine Society of Cardiology and participated in the meeting in Philadelphia.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Several studies suggest that the drug reduces the buildup of plaque in the arteries; in one of them, in patients with type 2 diabetes, </span><a href="https://www.mdpi.com/2227-9059/11/5/1362" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">four months of treatment with semaglutide</span></a><span class="sc-4df7a8a0-0 kkhobw"> reduced carotid artery thickness, a clinical marker of atherosclerosis, by 13 percent.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">A role for semaglutide and related drugs in staving off cardiovascular disease — the cause of one in three deaths worldwide — further boosts the drug’s prospects in the market by vastly expanding the universe of specialists who can prescribe it. It also repositions being overweight as one of the main truly modifiable risk factors for cardiovascular disease.</span></p><div id="dealing-with-extra-pounds" class="sc-81445bbc-0 gNbimG"><h2 class="sc-739331d9-0 iatIbm"><span class="sc-4df7a8a0-0 kkhobw">Dealing with Extra Pounds</span></h2></div><p><span class="sc-4df7a8a0-0 kkhobw">According to the classic medical approach, to lose weight there must be an imbalance between calories taken in and calories burned: You either eat fewer or expend more. But in the last 30 years, new evidence has shown it is far more complicated than</span><span class="sc-4df7a8a0-0 hmYLKc"> </span><span class="sc-4df7a8a0-0 kkhobw">that, says Julio César Montero, a medical nutritionist and president of the Argentine Society of Obesity and Eating Disorders.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">The emerging thinking among those working in this field, and reflected in a statement by the </span><a href="https://academic.oup.com/edrv/article/38/4/267/3892397" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">Endocrine Society</span></a><span class="sc-4df7a8a0-0 kkhobw">, is that obesity is due to two related but distinct processes: the already mentioned energy imbalance (eating more calories than the body expends) and the resetting of the body weight “set point” — the weight that the body determines as its goal — to a higher value.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">People with obesity have a disorder of the energy homeostasis system, the biological process that maintains weight stability by actively matching energy intake to energy expenditure over time. Thus, the body responds to weight loss by tenaciously trying to regain the lost pounds and return to its (higher value) target weight.</span></p><div class="sc-202ecc93-0 gAMfTf"><div class="lazyload-wrapper "><div style="height:433px" class="lazyload-placeholder"></div></div><div class="sc-202ecc93-1 dqnBTe">All current FDA-approved anti-obesity medications contribute to weight loss, although the results vary from one to another. Most of these compounds act at the brain level, to reduce appetite and increase satiety, and at the gastrointestinal level, to slow gastric emptying, promote insulin release or block fat absorption.</div></div><p><span class="sc-4df7a8a0-0 kkhobw">The mechanism behind the body’s quest to return to its body weight set point is not yet fully understood, but it explains why it is so difficult to achieve an effective treatment to manage obesity. It is estimated that only one in five people who lose between 5 and 10 percent of their initial weight through diet and exercise in six months manage to keep off the weight for more than a year. Losing and sustaining weight loss isn’t made easier by modernity’s </span><a href="https://www.annualreviews.org/content/journals/10.1146/annurev.anthro.35.081705.123301" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">sedentary way of life</span></a><span class="sc-4df7a8a0-0 kkhobw"> and the wide range of readily available </span><a href="https://knowablemagazine.org/content/article/food-environment/2023/what-can-we-do-about-ultraprocessed-foods" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">ultraprocessed foods</span></a><span class="sc-4df7a8a0-0 kkhobw">. By 2035, it’s projected that </span><a href="https://www.worldobesity.org/news/economic-impact-of-overweight-and-obesity-to-surpass-4-trillion-by-2035" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">more than half of the world’s population</span></a><span class="sc-4df7a8a0-0 kkhobw"> will be overweight or obese.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Until now, </span><a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00059-7/fulltext" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">traditional anti-obesity drugs</span></a><span class="sc-4df7a8a0-0 kkhobw"> have had limited effectiveness. Most act on brain-signaling chemicals — neurotransmitters — to reduce appetite, an approach pioneered in the 1960s with the use of amphetamines that has continued to today with safer derivatives and some other, nonamphetamine, drugs. Another often-used drug is orlistat (marketed as Alli or Xenical), which reduces fat absorption from food.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">But for all of these, the effects over the short and medium term are relatively modest, achieving a reduction of 6 percent to 10 percent of a person’s starting weight. Moreover, adverse effects, ranging from insomnia, nervousness and increased blood pressure to diarrhea and fecal incontinence, limit their widespread use.</span></p><div id="the-role-of-hormones" class="sc-81445bbc-0 gNbimG"><h2 class="sc-739331d9-0 iatIbm"><span class="sc-4df7a8a0-0 kkhobw">The Role of Hormones</span></h2></div><p><span class="sc-4df7a8a0-0 kkhobw">In search of new ways to understand and treat obesity, in recent decades scientists have turned their gaze to the hormones secreted by the intestine.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Specifically, research has focused on </span><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1642697/" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">a group of 10 hormones</span></a><span class="sc-4df7a8a0-0 kkhobw"> that have roles in optimizing the process of digestion and absorption of nutrients from the food we eat. They are also how the gastrointestinal tract sends signals to the brain about the body’s energy status, in many cases influencing metabolism and contributing to the regulation of our appetites.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">The new strategy “has changed the therapeutic landscape of obesity to target underlying mechanisms” and spurred “</span><a href="https://www.annualreviews.org/doi/10.1146/annurev-med-043021-014919" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">an auspicious new era of highly effective drugs</span></a><span class="sc-4df7a8a0-0 kkhobw">,” write endocrinologist Ania Jastreboff of Yale School of Medicine and her colleague Robert Kushner of Northwestern University in a 2023 article in the </span><span class="sc-4df7a8a0-0 cOwLcG">Annual Review of Medicine</span><span class="sc-4df7a8a0-0 kkhobw">.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">One such hormone is glucagon-like peptide type 1, or GLP-1, discovered in the 1980s. Semaglutide, the active molecule in Ozempic and Wegovy, is a lab-made lookalike that mimics the action of GLP-1. Like GLP-1 itself, and like an earlier drug, liraglutide, that was approved in 2010, it suppresses the release of glucagon — a hormone secreted by the pancreas to raise blood sugar levels. It also promotes the growth and function of pancreatic beta cells, which are responsible for producing insulin, the hormone that ensures that sugar from food enters the body’s cells to give them energy.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Both of these actions regulate blood sugar levels, which is why these drugs were initially intended to tackle diabetes. A series of </span><a href="https://pubmed.ncbi.nlm.nih.gov/30615985/" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">clinical trials called SUSTAIN</span></a><span class="sc-4df7a8a0-0 kkhobw">, which evaluated the drug in about 8,000 patients with type 2 diabetes, showed that semaglutide is more effective than other available drugs (sitagliptin, marketed as Januvia; exenatide, or Byetta; dulaglutide, or Trulicity; and insulin glargine, or Lantus) in reducing </span><a href="https://diabetes.org/about-diabetes/a1c" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">glycosylated hemoglobin</span></a><span class="sc-4df7a8a0-0 kkhobw"> scores — a test that measures average blood glucose levels over the prior three months. Maintaining blood sugar levels within the target range is a goal in the treatment of diabetes to avoid complications.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">But it was soon realized that these drugs came with a bonus, since GLP-1 doesn’t act only on the pancreas. It also acts on centers in the brain that control appetite. And it decreases stomach movements and emptying, so people feel full for longer. These two mechanisms contribute to reducing food intake, but, unlike older anti-obesity drugs, “they do so in a more physiological way, with few adverse effects,” says Montero. One of the best effects, he adds, is that they take away suffering, because they assuage food cravings. </span><a href="https://pubmed.ncbi.nlm.nih.gov/36655300/" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">Patients report</span></a><span class="sc-4df7a8a0-0 kkhobw"> a reduced desire to eat highly seasoned and salty foods, or foods rich in carbohydrates, as well as a better ability to resist urges.</span></p><div class="sc-202ecc93-0 gAMfTf"><div class="lazyload-wrapper "><div style="height:433px" class="lazyload-placeholder"></div></div><div class="sc-202ecc93-1 dqnBTe">Semaglutide, the active molecule of Ozempic and Wegovy, is a synthetic version of glucagon-like peptide type 1 or GLP-1. The functions of GLP-1 in the body are numerous, acting on the pancreas, stomach, gastrointestinal tract, kidneys, bones, heart, liver, muscle and adipose tissues, the energy-regulating center of the brain, and the rest of the neural system.</div></div><p><span class="sc-4df7a8a0-0 kkhobw">For Harwicz, semaglutide can be a facilitator that helps people make better decisions. One of her patients, a man weighing more than 160 kilograms (over 350 pounds) with a history of diabetes who had failed multiple previous attempts to lose weight, was able to lose 35 kilos (77 pounds) — more than 20 percent of his body weight — with weekly injections of the drug, along with dietary education and a tailored physical activity plan. “He really feels like he’s succeeding because the medication is helping him,” she says. “It’s important to modify lifestyle; medication isn’t magic. But people can make better food choices and reduce the amount they eat with a lot more peace of mind.”</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Of course, like any drug, semaglutide does not work in all patients, nor is it tolerated by all. In the SELECT study, for example, 16.6 percent of participants receiving semaglutide dropped out of the trial because of adverse effects, mainly digestive problems such as nausea, vomiting and diarrhea.</span></p><div id="more-in-the-pipeline" class="sc-81445bbc-0 gNbimG"><h2 class="sc-739331d9-0 iatIbm"><span class="sc-4df7a8a0-0 kkhobw">More in the Pipeline</span></h2></div><p><span class="sc-4df7a8a0-0 kkhobw">Everything indicates that the injections of semaglutide are just the beginning in this new era of weight loss drugs. In addition to a </span><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01185-6/abstract" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">high-dose oral version of semaglutide</span></a><span class="sc-4df7a8a0-0 kkhobw"> that showed promising effects in trials and is on the horizon for approval, a tsunami of clinical trial results is anticipated for new drugs that also operate on the gut-brain axis and re-create the action of other intestinal and pancreatic hormones.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">One of these is glucose-dependent insulinotropic polypeptide (GIP), which promotes insulin release after meals and reduces appetite. Another hormone is glucagon, which counterbalances the action of insulin by raising blood sugar, helps eliminate fat from the liver and increases satiety. And a third is amylin, which delays stomach emptying, accelerates satiety and decreases the desire to eat.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Collectively, such therapies have been dubbed “nutrient-stimulated hormone-based treatments” because they mimic the action of hormones that are released or function when specialized sensor cells in the digestive tract detect food intake. And they promise to enhance slimming effects, alone or in combination, partly through a physiological reset that prevents the body from stubbornly returning to a weight range that seems predetermined. In other words, it reduces the body’s tendency to regain the lost pounds.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">One of the newer drugs, tirzepatide from Eli Lilly (marketed as Mounjaro or Zepbound), acts both on GLP-1 and GIP receptors. It </span><a href="https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management#:~:text=Today%2C%20the%20U.S.%20Food%20and,weight%2Drelated%20condition%20(such%20as" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">obtained FDA approval November 2023</span></a><span class="sc-4df7a8a0-0 kkhobw"> for the treatment of obesity. </span><a href="https://jamanetwork.com/journals/jama/fullarticle/2812936" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">One of the clinical studies</span></a><span class="sc-4df7a8a0-0 kkhobw"> of this drug reported an average decrease of 25.3 percent of initial weight in those who received a weekly injection for 88 weeks.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Another experimental drug from Eli Lilly, retatrutide — dubbed “triple G” because it acts on GLP-1, GIP and glucagon receptors — could be next on the list. Last June, a study led by Jastreboff </span><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2301972" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">reported weight declines never before seen with a single drug</span></a><span class="sc-4df7a8a0-0 kkhobw">. Patients without diabetes averaged a 24 percent body weight loss in just 48 weeks (11 months). And in the group receiving the highest dose, one-fourth of the patients dropped more than 30 percent of their weight. That’s close to the results of highly effective, but more drastic, bariatric surgery.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">“I never imagined that physicians would have to worry about our patients losing </span><span class="sc-4df7a8a0-0 cOwLcG">too </span><span class="sc-4df7a8a0-0 kkhobw">much weight when taking an anti-obesity drug,” Kushner says. “This is really an interesting turning point in obesity science and practice, an important paradigm shift in how we think about and manage people living with obesity.”</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Kushner and Jastreboff suggest in their article that combining various members of these hormone-based drugs could target the many intertwined mechanisms of obesity. Montero agrees: “There is a swarm of hormones that form a spider web. And touching more than one thread at a time may move the web better, potentiating the effect and making interventions more comfortable, with fewer adverse events,” he says.</span></p><div class="sc-202ecc93-0 gAMfTf"><div class="lazyload-wrapper "><div style="height:433px" class="lazyload-placeholder"></div></div><div class="sc-202ecc93-1 dqnBTe">A number of gut hormones have attracted scientific attention as potential therapeutic targets for the management of obesity.</div></div><p><span class="sc-4df7a8a0-0 kkhobw">What is more, semaglutide and tirzepatide could also have benefits in other diseases, such as </span><a href="https://www.nature.com/articles/s41598-023-48267-2" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">alcohol abuse disorder</span></a><span class="sc-4df7a8a0-0 kkhobw"> and other compulsive or addictive behaviors, such as smoking, excessive shopping and nail-biting. The drugs also </span><a href="https://www.kidney-international.org/article/S0085-2538(23)00756-1/fulltext" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">reduce inflammation</span></a><span class="sc-4df7a8a0-0 kkhobw">, which could help to limit damage to various organs and structures, such as the kidneys and joints. There are also preliminary studies of the effects of the drug in preventing </span><a href="https://onlinelibrary.wiley.com/doi/10.1002/oby.23772" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">cancer</span></a><span class="sc-4df7a8a0-0 kkhobw">, and for the treatment of </span><a href="https://pubmed.ncbi.nlm.nih.gov/30741689/" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">Parkinson’s</span></a><span class="sc-4df7a8a0-0 kkhobw"> and </span><a href="https://pubmed.ncbi.nlm.nih.gov/37730113/" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">Alzheimer’s</span></a><span class="sc-4df7a8a0-0 kkhobw">, although further studies are still needed to confirm their results. Writing in 2023, the editors of the journal </span><a href="https://www.aaas.org/news/sciences-2023-breakthrough-glp-1-agonists-show-promise-against-obesity-associated-disease" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 cOwLcG">Science</span></a><span class="sc-4df7a8a0-0 kkhobw"> declared that no scientific breakthrough in that year had been so transformative in so many fields, affecting everything from financial markets to popular culture.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">But, as with any medical innovation, unavoidable challenges also loom on the horizon. Although the visible adverse effects of GLP-1 receptor agonists — nausea, vomiting, constipation and diarrhea — are usually mild and limited to the gastrointestinal tract, other more unusual but serious complications have raised concerns, such as a possible increased risk of pancreatitis. In addition, animal studies (not yet demonstrated in humans) suggest that there is a link to thyroid cancer risk.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Another barrier is the cost of these drugs. In the United States, a monthly treatment with semaglutide costs almost $1,000; the price drops almost 10-fold in countries such as Japan, the United Kingdom and Australia. In Latin America, where obesity rates have grown faster than in other parts of the world, the drug remains unaffordable for the bulk of the population. In Argentina, for example, in March an Ozempic pen with four doses of 1 mg cost 409,000 pesos, which is equivalent to more than twice the monthly minimum wage. More than two pens per month would be required to reach the 2.4 mg per week dose used in the SELECT cardiovascular prevention study.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">To make matters worse, studies show that the benefits on weight fade or diminish sharply when the treatment is stopped, so it would have to be continued long-term. Research published in 2022, for example, found that patients </span><a href="https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14725" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">regained two-thirds of their lost weight within a year of stopping medication.</span></a><span class="sc-4df7a8a0-0 kkhobw"></span></p><p><span class="sc-4df7a8a0-0 kkhobw">“Our enthusiasm as clinicians with these drugs wanes if you think about it from a public health point of view,” says Patricio López Jaramillo, an endocrinologist, researcher and rector of the University of Santander in Bucaramanga, Colombia. He thinks that the use of the drugs should be placed within a broader societal package that extends beyond “the rational, linear and disciplinary vision” of medical specialists.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">“New anti-obesity drugs should be considered as a useful tool, if financial access is improved,” he says. “And [use] must be framed within global actions and programs that allow populations to have real possibilities to practice healthy lifestyle habits, such as exercising, following a balanced diet and staying away from smoking.”</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Kushner says physicians need to reexamine the kind of lifestyle advice given to people receiving these new drugs, de-emphasizing calorie counting and daily weigh-ins. More focus should be placed on health impacts rather than weight loss, high-quality protein intake should be encouraged, and the importance of physical activity and resistance exercise to preserve muscle mass should be emphasized.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">One option could be to use tests to predict which patients will have better results with the various medications and who, perhaps, should think about surgery or other approaches. “Not all patients respond to treatment,” says Andrés Acosta, an Ecuadorian physician and researcher who heads the </span><a href="https://www.mayo.edu/research/labs/precision-medicine-obesity/overview" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">Precision Obesity Medicine Laboratory</span></a><span class="sc-4df7a8a0-0 kkhobw"> at the Mayo Clinic in Rochester, Minnesota. It is important to identify those who would benefit most, he adds.</span></p><p><span class="sc-4df7a8a0-0 kkhobw">Acosta cofounded a company that last year launched a test that identifies patients with a feature called “hungry gut” — those who move food quickly from their stomachs and, consequently, lose satiety faster. This could be a subgroup that particularly benefits from these new anti-obesity drugs, he hypothesizes. For a drug market that could be worth $100 billion by 2030, it wouldn’t hurt to ensure that resources are invested in the patients who will get the most from them.</span></p><p><span class="sc-4df7a8a0-0 cOwLcG">Editor’s note: This article was updated on April 17, 2024, to correct the location of the Mayo Clinic. It is in Rochester, Minnesota, not Rochester, New York, as originally stated.</span><span class="sc-4df7a8a0-0 kkhobw"> </span></p><hr class="sc-c49dd42c-0 gUBdPx"/><p><span class="sc-4df7a8a0-0 cOwLcG">10.1146/knowable-041724-1</span><span class="sc-4df7a8a0-0 kkhobw"> </span></p><p><span class="sc-4df7a8a0-0 fsjKLm">Matías A. Loewy</span><span class="sc-4df7a8a0-0 cOwLcG"> is a science journalist based in Buenos Aires, Argentina. He remembers that when he was a pharmacy student at the University of Buenos Aires, the only treatments for obesity were based on dangerous amphetamine derivatives. For now, he keeps his weight more or less under control. </span></p><p><span class="sc-4df7a8a0-0 cOwLcG">This article originally appeared in </span><a href="https://knowablemagazine.org/content/article/health-disease/2024/whats-next-in-the-ozempic-era" class="sc-acb0869a-0 bxBBvR sc-be2fc1e4-0 jhHupj" color="accent" target="_blank" rel="noopener"><span class="sc-4df7a8a0-0 kkhobw">Knowable Magazine</span></a><span class="sc-4df7a8a0-0 cOwLcG">, an independent journalistic endeavor from Annual Reviews.</span></p></article><ul class="sc-fc31822f-0 hULpA-D"><li class="sc-de217756-0 cSQUFG"><a class="sc-acb0869a-0 cgZEsQ" href="/tag/wellness">wellness</a></li></ul><div class="sc-aeb3ddd8-0 fIkXwQ"><div class="sc-e64f09bb-0 kRJNMy"><div class="sc-e64f09bb-1 hNEEqm">1<!-- --> free <!-- -->article<!-- --> left</div><div class="sc-e64f09bb-2 eZzrtd">Want More? Get unlimited access for as low as $1.99/month</div><div class="sc-e64f09bb-3 NnTsm"><a href="https://kalmbach.dragonforms.com/loading.do?omedasite=DSS_New&amp;pk=DSF43D8" class="sc-acb0869a-0 cgZEsQ sc-f3730634-0 cOuSSg" target="_blank" rel="noopener">Subscribe</a></div><div class="sc-e64f09bb-4 kLscOL"><div class="sc-3ef8760c-0 eCfiVt"><p class="sc-3ef8760c-2 gdFmEX">Already a subscriber?</p><p class="sc-3ef8760c-2 gdFmEX"><a class="sc-acb0869a-0 cgZEsQ sc-3ef8760c-1 dnIUZI">Register</a> <!-- -->or <a class="sc-acb0869a-0 cgZEsQ sc-3ef8760c-1 dnIUZI">Log In</a></p></div></div></div><div class="sc-a2aa4e38-0 bntQfD"><div class="sc-a2aa4e38-1 jcjUUT"><span class="sc-a2aa4e38-2 fYazMM">1<!-- --> free <!-- -->article</span><a href="https://kalmbach.dragonforms.com/loading.do?omedasite=DSS_New&amp;pk=DSF43D1" class="sc-acb0869a-0 cgZEsQ sc-f3730634-0 cOuSSg" target="_blank" rel="noopener">Subscribe</a><button aria-label="Show subscription benefits" class="sc-a2aa4e38-3 dhwHRZ"><svg viewBox="0 0 24 24" width="20" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="m12 8-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z"></path></svg></button></div><div class="sc-24a7fbea-0 gzwArZ"><div class="sc-24a7fbea-1 hGxOas"><img src="/assets/globalAssets/DSC_white_small.png" alt="Discover Magazine Logo" height="215px" class="sc-e706b2c9-0 cBLqYz"/><div class="sc-24a7fbea-2 jqQDPZ">Want more?</div><p class="sc-24a7fbea-3 FJGVX">Keep reading for as low as $1.99!</p><p><a href="https://kalmbach.dragonforms.com/loading.do?omedasite=DSS_New&amp;pk=DSF43D1" class="sc-acb0869a-0 cgZEsQ sc-f3730634-0 iMktqk" target="_blank" rel="noopener">Subscribe</a></p><div class="sc-3ef8760c-0 eCfiVt"><p class="sc-3ef8760c-2 gdFmEX">Already a subscriber?</p><p class="sc-3ef8760c-2 gdFmEX"><a class="sc-acb0869a-0 cgZEsQ sc-3ef8760c-1 dnIUZI">Register</a> <!-- -->or <a class="sc-acb0869a-0 cgZEsQ sc-3ef8760c-1 dnIUZI">Log In</a></p></div></div></div></div></div></div></div></div><div class="sc-87d213a0-0 gdbaPI"><div class="sc-4fbbd49c-0 jeZlQy"><span class="sc-4fbbd49c-1 EckBW">More From Discover</span></div><div class="sc-a30dccf3-0 brMNmo"><div class="sc-61d99178-0 dkOAOU"><div><a aria-label="Gut Microbes That Get You Drunk And Damage Your Liver" class="sc-acb0869a-0 cgZEsQ" style="position:relative" href="/health/gut-microbes-that-get-you-drunk-and-damage-your-liver"><div class="lazyload-wrapper "><div style="height:205px" class="lazyload-placeholder"></div></div></a></div><div><a class="sc-acb0869a-0 cgZEsQ sc-4e016ad2-0 dAELGB" href="/health">Health</a></div><a class="sc-acb0869a-0 cgZEsQ sc-61d99178-1 eSTMOo" href="/health/gut-microbes-that-get-you-drunk-and-damage-your-liver">Gut Microbes That Get You Drunk And Damage Your Liver</a></div><div class="sc-61d99178-0 dkOAOU"><div><a aria-label="Here’s How To Avoid These 3 Types of Age-Related Vision Loss" class="sc-acb0869a-0 cgZEsQ" style="position:relative" href="/health/heres-how-to-avoid-these-3-types-of-age-related-vision-loss"><div class="lazyload-wrapper "><div style="height:205px" class="lazyload-placeholder"></div></div></a></div><div><a class="sc-acb0869a-0 cgZEsQ sc-4e016ad2-0 dAELGB" href="/health">Health</a></div><a class="sc-acb0869a-0 cgZEsQ sc-61d99178-1 eSTMOo" href="/health/heres-how-to-avoid-these-3-types-of-age-related-vision-loss">Here’s How To Avoid These 3 Types of Age-Related Vision Loss</a></div><div class="sc-61d99178-0 dkOAOU"><div><a aria-label="Chemical Pollutants Can Change Your Skin Bacteria, Increasing Eczema Risk" class="sc-acb0869a-0 cgZEsQ" style="position:relative" href="/health/chemical-pollutants-can-change-your-skin-bacteria-increasing-eczema-risk"><div class="lazyload-wrapper "><div style="height:205px" class="lazyload-placeholder"></div></div></a></div><div><a class="sc-acb0869a-0 cgZEsQ sc-4e016ad2-0 dAELGB" href="/health">Health</a></div><a class="sc-acb0869a-0 cgZEsQ sc-61d99178-1 eSTMOo" href="/health/chemical-pollutants-can-change-your-skin-bacteria-increasing-eczema-risk">Chemical Pollutants Can Change Your Skin Bacteria, Increasing Eczema Risk</a></div><div class="sc-61d99178-0 dkOAOU"><div><a aria-label="It Doesn&#x27;t Take Long to Reset Your Gut Health With Small Lifestyle Changes" class="sc-acb0869a-0 cgZEsQ" style="position:relative" href="/health/it-doesnt-take-long-to-reset-your-gut-health-with-small-lifestyle-changes"><div class="lazyload-wrapper "><div style="height:205px" class="lazyload-placeholder"></div></div></a></div><div><a class="sc-acb0869a-0 cgZEsQ sc-4e016ad2-0 dAELGB" href="/health">Health</a></div><a class="sc-acb0869a-0 cgZEsQ sc-61d99178-1 eSTMOo" href="/health/it-doesnt-take-long-to-reset-your-gut-health-with-small-lifestyle-changes">It Doesn&#x27;t Take Long to Reset Your Gut Health With Small Lifestyle Changes</a></div><div class="sc-61d99178-0 dkOAOU"><div><a aria-label="Beyond Weight Loss and Diabetes, Ozempic Could Help Certain Heart Conditions" class="sc-acb0869a-0 cgZEsQ" style="position:relative" href="/health/beyond-weight-loss-and-diabetes-ozempic-could-help-certain-heart-conditions"><div class="lazyload-wrapper "><div style="height:205px" class="lazyload-placeholder"></div></div></a></div><div><a class="sc-acb0869a-0 cgZEsQ sc-4e016ad2-0 dAELGB" href="/health">Health</a></div><a class="sc-acb0869a-0 cgZEsQ sc-61d99178-1 eSTMOo" href="/health/beyond-weight-loss-and-diabetes-ozempic-could-help-certain-heart-conditions">Beyond Weight Loss and Diabetes, Ozempic Could Help Certain Heart Conditions</a></div><div class="sc-61d99178-0 dkOAOU"><div><a aria-label="Does Bubble Tea Have Any Health Benefits?" class="sc-acb0869a-0 cgZEsQ" style="position:relative" href="/health/does-bubble-tea-have-any-health-benefits"><div class="lazyload-wrapper "><div style="height:205px" class="lazyload-placeholder"></div></div></a></div><div><a class="sc-acb0869a-0 cgZEsQ sc-4e016ad2-0 dAELGB" href="/health">Health</a></div><a class="sc-acb0869a-0 cgZEsQ sc-61d99178-1 eSTMOo" href="/health/does-bubble-tea-have-any-health-benefits">Does Bubble Tea Have Any Health Benefits?</a></div></div><section class="sc-a7a77854-1 fmhyDa"><div class="sc-4fbbd49c-0 jeZlQy"><span class="sc-4fbbd49c-1 EckBW">Recommendations From Our Store</span></div><div><div class="sc-53249186-0 gplNqD"><div class="sc-6fbfc10d-0 bJxiBI"><div style="opacity:0" class="sc-37efb70a-0 durxKK"><div width="0" class="sc-c6956122-0 bzmMhn"><div class="sc-8eaa343d-0 bJeNAn"><a href="https://myscienceshop.com/product/gift/82404" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-1 gcujOa" aria-label="Periodic Mug" target="_blank" rel="noopener"><div class="lazyload-wrapper "><div style="height:180px" class="lazyload-placeholder"></div></div></a><hr class="sc-8eaa343d-2 ixbrMF"/><a href="https://myscienceshop.com/" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-3 djqOxY" target="_blank" rel="noopener">My Science Shop</a><a href="https://myscienceshop.com/product/gift/82404" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-4 kaFnJo" target="_blank" rel="noopener">Periodic Mug</a></div></div><div width="0" class="sc-c6956122-0 bzmMhn"><div class="sc-8eaa343d-0 bJeNAn"><a href="https://myscienceshop.com/product/stem-toy/82402" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-1 gcujOa" aria-label="Foucault&#x27;s Pendulum" target="_blank" rel="noopener"><div class="lazyload-wrapper "><div style="height:180px" class="lazyload-placeholder"></div></div></a><hr class="sc-8eaa343d-2 ixbrMF"/><a href="https://myscienceshop.com/" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-3 djqOxY" target="_blank" rel="noopener">My Science Shop</a><a href="https://myscienceshop.com/product/stem-toy/82402" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-4 kaFnJo" target="_blank" rel="noopener">Foucault&#x27;s Pendulum</a></div></div><div width="0" class="sc-c6956122-0 bzmMhn"><div class="sc-8eaa343d-0 bJeNAn"><a href="https://myscienceshop.com/catalog/stem-toys?filters=d45e08f03e9445408452b70ccbacfd9d" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-1 gcujOa" aria-label="Discover STEM Kits" target="_blank" rel="noopener"><div class="lazyload-wrapper "><div style="height:180px" class="lazyload-placeholder"></div></div></a><hr class="sc-8eaa343d-2 ixbrMF"/><a href="https://myscienceshop.com/" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-3 djqOxY" target="_blank" rel="noopener">My Science Shop</a><a href="https://myscienceshop.com/catalog/stem-toys?filters=d45e08f03e9445408452b70ccbacfd9d" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-4 kaFnJo" target="_blank" rel="noopener">Discover STEM Kits</a></div></div><div width="0" class="sc-c6956122-0 bzmMhn"><div class="sc-8eaa343d-0 bJeNAn"><a href="https://myscienceshop.com/search?q=Elements+Flashcards" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-1 gcujOa" aria-label="Elements Flashcards" target="_blank" rel="noopener"><div class="lazyload-wrapper "><div style="height:180px" class="lazyload-placeholder"></div></div></a><hr class="sc-8eaa343d-2 ixbrMF"/><a href="https://myscienceshop.com/" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-3 djqOxY" target="_blank" rel="noopener">My Science Shop</a><a href="https://myscienceshop.com/search?q=Elements+Flashcards" class="sc-acb0869a-0 cgZEsQ sc-8eaa343d-4 kaFnJo" target="_blank" rel="noopener">Elements Flashcards</a></div></div></div></div><button disabled="" class="sc-b4fec831-0 jVpYly"><div class="sc-5145e07e-0 fFLeJP"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M15.41 7.41 14 6l-6 6 6 6 1.41-1.41L10.83 12z"></path></svg></div></button><button class="sc-b4fec831-0 gHCgCv"><div class="sc-5145e07e-0 fFLeJP"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"></path></svg></div></button></div></div><a href="https://myscienceshop.com/" class="sc-acb0869a-0 cgZEsQ sc-a7a77854-2 hYUFsa" target="_blank" rel="noopener">Shop Now</a></section><div class="sc-bb8c2e70-0 dEvxDw"><div class="sc-ea6cad81-0 bkOpQU"><div class="sc-ea6cad81-1 dtcmRn">Stay Curious</div></div><div class="sc-bb8c2e70-1 gaMYLq"><div class="sc-bb8c2e70-2 iOtZCv"><div class="sc-a0a15a8f-0 cbcdaX"><div class="sc-a0a15a8f-1 dORPcO"><div class="sc-a0a15a8f-2 bPMdAY">Join</div><div class="sc-a0a15a8f-3 bmSFuJ">Our List</div></div><p class="sc-539cc9d9-0 fwcCIP">Sign up for our weekly science updates.</p><form class="sc-dd7abf72-0 eztMZN"><div class="sc-dd7abf72-1 eifopM"><input aria-label="Email Address" autoComplete="email" placeholder="Email Address" class="sc-335967e1-0 glnGeY"/><button aria-label="Sign Up for Newsletter" type="submit" color="hsl(4, 68%, 52%)" class="sc-c8bbe1ac-0 sc-b65b6186-0 haeKWy OrBVy">Sign Up</button></div><div class="sc-92081554-0 fChjmv"> </div></form><div class="sc-539cc9d9-1 hGVYrY"><a href="https://www.kalmbach.com/privacy/" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener">View our privacy policy</a></div></div><div class="sc-a0a15a8f-0 cbcdaX"><div class="sc-a0a15a8f-1 dORPcO"><div class="sc-a0a15a8f-2 bPMdAY">Subscribe</div><div class="sc-a0a15a8f-3 bmSFuJ">To The Magazine</div></div><p class="sc-8c045442-0 ernAPE">Save up to <span class="sc-8c045442-1 XCZAi">40% off</span> the cover price when you subscribe to <em>Discover</em> magazine.</p><div class="sc-8c045442-2 kBtZqG"><a href="https://kalmbach.dragonforms.com/loading.do?omedasite=DSS_New&amp;pk=DSF43D1" class="sc-acb0869a-0 cgZEsQ sc-f3730634-0 sc-8c045442-3 bgntqP NNFyi" target="_blank" rel="noopener">Subscribe</a></div></div></div></div></div></div><div class="sc-e3de11d5-0 SiWEt"><div class="sc-e3de11d5-1 dIiUhA"><div class="sc-6832a32a-0 izHfgR"><div class="lazyload-wrapper "><div style="height:146px" class="lazyload-placeholder"></div></div><div class="sc-6832a32a-1 eFVKFk"><a href="https://www.facebook.com/DiscoverMag" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener"><img src="/assets/socialIcons/facebook.png" alt="Facebook" height="50px" width="50px" class="sc-e706b2c9-0 cBpdBS"/></a><a href="https://www.instagram.com/discover.magazine" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener"><img src="/assets/socialIcons/instagram.png" alt="Instagram" height="50px" width="50px" class="sc-e706b2c9-0 cBpdBS"/></a><a href="https://twitter.com/discovermag" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener"><img src="/assets/socialIcons/twitter.png" alt="Twitter" height="50px" width="50px" class="sc-e706b2c9-0 cBpdBS"/></a><a href="https://www.youtube.com/user/discovermagazine" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener"><img src="/assets/socialIcons/youtube.png" alt="YouTube" height="50px" width="50px" class="sc-e706b2c9-0 cBpdBS"/></a><a href="https://soundcloud.com/its-only-science-discover-magazine" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener"><img src="/assets/socialIcons/soundcloud.png" alt="Soundcloud" height="50px" width="50px" class="sc-e706b2c9-0 cBpdBS"/></a><a class="sc-acb0869a-0 cgZEsQ" href="/rss"><img src="/assets/socialIcons/rss.png" alt="RSS" height="50px" width="50px" class="sc-e706b2c9-0 cBpdBS"/></a></div></div><div class="sc-131d9e26-0 iqmVao"><a class="sc-acb0869a-0 cgZEsQ" href="/magazine">The Magazine</a><a class="sc-acb0869a-0 cgZEsQ" href="/about">About Discover</a><a href="https://www.myscienceshop.com/?utm_source=discovermag&amp;utm_medium=website&amp;utm_campaign=site_footer" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener">Shop Our Store</a><a href="https://www.kalmbach.com/privacy" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener">Privacy Policy</a><a href="https://kalmbach.dragonforms.com/loading.do?omedasite=DSS_New&amp;pk=DSF43D1" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener">Subscribe</a><a class="sc-acb0869a-0 cgZEsQ" href="/advertise">Advertise</a><a class="sc-acb0869a-0 cgZEsQ" href="/newsletter-signup">Newsletter</a><a href="https://www.kalmbach.com/termsofuse" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener">Terms of Use</a><a href="https://kalmbach.dragonforms.com/loading.do?omedasite=DSC_custserv" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener">Customer Service</a><a class="sc-acb0869a-0 cgZEsQ" href="/contact-us">Contact</a><a href="https://www.kalmbach.com/copyrightpolicy" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener">Copyright Policy</a></div></div></div><div class="sc-e3de11d5-2 hJGlvP"><div><span>Copyright © <!-- -->2024<!-- --> </span><a href="https://www.kalmbach.com/copyrightpolicy" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener">Kalmbach Media Co.</a></div><div class="sc-f2c05f19-0 oUyxt"><a href="https://www.kalmbach.com/accessibility-statement" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener">Website Accessibility</a></div></div><div role="button" tabindex="0" aria-label="Dismiss Dialog" class="sc-bdc700bb-0 bmCIia"></div><div class="sc-c114e581-0 kYxrvQ"><div class="sc-c114e581-1 jXVATq"><div class="sc-93418c49-0 gecSKd"><button aria-label="Close Sidebar" class="sc-93418c49-1 lbrRCn"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"></path></svg></button></div><nav><ul class="sc-5ef19ac2-0 bppzWr"><li class="sc-16326799-0 fLfSeK"><a class="sc-acb0869a-0 cgZEsQ" href="/magazine"><div class="sc-16326799-1 edRbLk">The Magazine</div><div class="sc-16326799-2 gDzKSJ"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"></path></svg></div></a></li><li class="sc-16326799-0 fLfSeK"><a href="https://myscienceshop.com/?utm_source=discovermag&amp;utm_medium=website&amp;utm_campaign=site_header" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener"><div class="sc-16326799-1 edRbLk">Shop</div><div class="sc-16326799-2 gDzKSJ"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"></path></svg></div></a></li><li class="sc-16326799-0 fLfSeK"><a class="sc-acb0869a-0 cgZEsQ" href="/the-sciences"><div class="sc-16326799-1 edRbLk">The Sciences</div><div class="sc-16326799-2 gDzKSJ"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"></path></svg></div></a></li><li class="sc-16326799-0 fLfSeK"><a class="sc-acb0869a-0 cgZEsQ" href="/mind"><div class="sc-16326799-1 edRbLk">Mind</div><div class="sc-16326799-2 gDzKSJ"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"></path></svg></div></a></li><li class="sc-16326799-0 fLfSeK"><a class="sc-acb0869a-0 cgZEsQ" href="/technology"><div class="sc-16326799-1 edRbLk">Technology</div><div class="sc-16326799-2 gDzKSJ"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"></path></svg></div></a></li><li class="sc-16326799-0 fLfSeK"><a class="sc-acb0869a-0 cgZEsQ" href="/health"><div class="sc-16326799-1 edRbLk">Health</div><div class="sc-16326799-2 gDzKSJ"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"></path></svg></div></a></li><li class="sc-16326799-0 fLfSeK"><a class="sc-acb0869a-0 cgZEsQ" href="/environment"><div class="sc-16326799-1 edRbLk">Environment</div><div class="sc-16326799-2 gDzKSJ"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"></path></svg></div></a></li><li class="sc-16326799-0 fLfSeK"><a class="sc-acb0869a-0 cgZEsQ" href="/planet-earth"><div class="sc-16326799-1 edRbLk">Planet Earth</div><div class="sc-16326799-2 gDzKSJ"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"></path></svg></div></a></li><li class="sc-16326799-0 fLfSeK"><a href="https://kalmbach.dragonforms.com/loading.do?omedasite=DSS_New&amp;pk=DSF43D1" class="sc-acb0869a-0 cgZEsQ" target="_blank" rel="noopener"><div class="sc-16326799-1 edRbLk">Subscribe</div><div class="sc-16326799-2 gDzKSJ"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="StyledIconBase-sc-ea9ulj-0 ebjPRL"><path d="M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"></path></svg></div></a></li></ul></nav><div class="sc-342deb74-0 duTNrl"><div class="lazyload-wrapper "><div class="lazyload-placeholder"></div></div><div class="sc-342deb74-1 kZLSoz"><a class="sc-acb0869a-0 cgZEsQ sc-f3730634-0 ckUKXg">Login</a></div></div></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"page":{"title":"What’s Next In The Ozempic Era?","path":"/health/whats-next-in-the-ozempic-era","announce":{"text":"We have completed maintenance on DiscoverMagazine.com and action may be required on your account. Learn More","link":"https://www.discovermagazine.com/maintenance"},"slug":"whats-next-in-the-ozempic-era","adTargetingId":null},"permission":{"isAuthenticated":false,"hasAccess":true,"viewsRemaining":1,"isEntitled":false,"meterHasReduced":false,"previouslyMetered":false,"exceedsLimit":false},"user":{"isLoggedIn":false,"hasMagazineSub":false,"hasNewsletterSub":false,"newsletterSelections":[]},"content":{"article":{"id":"29beVHUNJ8RpjyISGxQH5p","meta":{"publicationDate":"2024-04-25T14:00-05:00","template":"Standard","contentIndex":"None","mostPopular":false,"featured":false,"paywall":true,"modifiedDate":"2024-04-25T19:00:02.977Z","excludeFromListing":false,"canonicalUrl":"https://www.discovermagazine.com/health/whats-next-in-the-ozempic-era","articleType":"News"},"refs":{"authors":[{"id":"uAJZlK7gH05znscENP75g","name":"Matías A. Loewy, Knowable Magazine","slug":"matias-a-loewy-knowable-magazine","image":{},"hideRightRail":false}],"category":{"id":"1TljbtPL83DpobaGeEmgsc","name":"Health","slug":"health","sortOrder":1,"hideRightRail":false,"image":{}},"tags":[{"id":"7ggDYP0OTNwUy9rp0E11oy","name":"wellness","slug":"wellness","image":{},"hideRightRail":false}]},"title":"What’s Next In The Ozempic Era?","subtitle":"Diabetes, weight loss and now heart health: A new family of drugs is changing the way scientists are thinking about obesity — and more uses are on the horizon","slug":"whats-next-in-the-ozempic-era","image":{"id":"64FrvaM7dXAkdp1SirxJMG","title":"ozempic-8282315 1280","description":"Image by Markus Winkler from Pixabay","url":"//images.ctfassets.net/cnu0m8re1exe/64FrvaM7dXAkdp1SirxJMG/fb905076e6fb05b3e4f3892b6be0e369/ozempic-8282315_1280.jpg"},"body":{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Few drugs have achieved the stardom that semaglutide, marketed in the United States as Ozempic or Wegovy, has today. A synthetic, injectable version of an intestinal hormone, it is the flagship of a new category of drugs initially developed for diabetes that rose to fame in the medical and public arena as an effective weapon against obesity. Semaglutide has proved so successful that its manufacturer, the Danish company Novo Nordisk, is unable to keep up with demand.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The US Food and Drug Administration approved semaglutide in 2017 to improve the control of blood sugar levels in adults with type 2 diabetes — and then, in June 2021, ","nodeType":"text"},{"data":{"uri":"https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014"},"content":[{"data":{},"marks":[],"value":"for chronic weight management in adults who are obese or overweight","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" and have related risk factors, such as high blood pressure or diabetes.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"","nodeType":"text"},{"data":{"uri":"https://mashable.com/article/wegovy-ozempic-kim-kardashian-weight-loss"},"content":[{"data":{},"marks":[],"value":"Social networks boosted the drug’s fame","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":": In mid-2022, a viral TikTok clip claimed Kim Kardashian had used semaglutide to lose 15 pounds so that she could wear an iconic Marilyn Monroe dress to the Met Gala in New York. In the months that followed, everyone from former British Prime Minister Boris Johnson to billionaire entrepreneur Elon Musk acknowledged resorting to the medication to tamp down their appetites and slim down. Today, ","nodeType":"text"},{"data":{"uri":"https://www.pewresearch.org/science/2024/02/26/how-americans-view-weight-loss-drugs-and-their-potential-impact-on-obesity-in-the-u-s/"},"content":[{"data":{},"marks":[],"value":"three out of four Americans say they have heard of this type of drug","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" — and of those, more than half consider it a good option for weight loss, according to a Pew Research survey.","nodeType":"text"}],"nodeType":"paragraph"},{"nodeType":"insticator","data":{},"marks":[]},{"data":{},"content":[{"data":{},"marks":[],"value":"Last November, however, the ones with their eyes on the drug were cardiologists. At the opening of the 2023 annual meeting of the American Heart Association in Philadelphia, results of a clinical trial generated tremendous interest: Semaglutide, it appeared, was a new tool to treat heart disease.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The trial, ","nodeType":"text"},{"data":{"uri":"https://www.nejm.org/doi/full/10.1056/NEJMoa2307563"},"content":[{"data":{},"marks":[],"value":"called SELECT, was conducted in 41 countries with more than 17,000","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" people who were overweight or obese and at high cardiovascular risk but who didn’t have diabetes. It found that a weekly subcutaneous injection of 2.4 milligrams of semaglutide can, in addition to helping people lose an average of 15 percent of their original weight, reduce the risk of heart attack, stroke or death by 20 percent. It’s a magnitude of effect that puts it in the same category as other drugs that prevent cardiovascular events, such as low-dose aspirin, antihypertensives and statins to lower ","nodeType":"text"},{"data":{"uri":"https://knowablemagazine.org/content/article/health-disease/2024/cholesterol-and-heart-disease-explained"},"content":[{"data":{},"marks":[],"value":"cholesterol","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":".","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"From the study, scientists could calculate the total number of people who would need to be treated to produce the desired benefit in one of them. They found that treating 67 diabetes-free overweight or obese patients at high risk of a cardiovascular event for 40 months would prevent one major cardiovascular event, such as heart attack or stroke, or death due to heart disease. By way of comparison, this is the same number of patients with a cardiovascular history who must take ","nodeType":"text"},{"data":{"uri":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838845/"},"content":[{"data":{},"marks":[],"value":"aspirin","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" or ","nodeType":"text"},{"data":{"uri":"https://thennt.com/nnt/anti-hypertensives-to-prevent-death-heart-attacks-and-strokes/"},"content":[{"data":{},"marks":[],"value":"hypertension drugs","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" for 60 months to avoid one stroke.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Based on the study results, in early March ","nodeType":"text"},{"data":{"uri":"https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or"},"content":[{"data":{},"marks":[],"value":"the FDA approved the use of injectable semaglutide to reduce the risk of cardiovascular death","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", myocardial infarction and stroke in adults with cardiovascular disease who are obese or overweight.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"“It’s a milestone. For the first time, we have a drug, semaglutide, that not only causes weight loss, but also reduces the formation of atherosclerotic plaque and prevents deaths and cardiovascular events,” says Paola Harwicz, a cardiologist and obesity specialist in Buenos Aires who headed the Cardiometabolism Council of the Argentine Society of Cardiology and participated in the meeting in Philadelphia.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Several studies suggest that the drug reduces the buildup of plaque in the arteries; in one of them, in patients with type 2 diabetes, ","nodeType":"text"},{"data":{"uri":"https://www.mdpi.com/2227-9059/11/5/1362"},"content":[{"data":{},"marks":[],"value":"four months of treatment with semaglutide","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" reduced carotid artery thickness, a clinical marker of atherosclerosis, by 13 percent.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"A role for semaglutide and related drugs in staving off cardiovascular disease — the cause of one in three deaths worldwide — further boosts the drug’s prospects in the market by vastly expanding the universe of specialists who can prescribe it. It also repositions being overweight as one of the main truly modifiable risk factors for cardiovascular disease.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Dealing with Extra Pounds","nodeType":"text"}],"nodeType":"heading-2"},{"data":{},"content":[{"data":{},"marks":[],"value":"According to the classic medical approach, to lose weight there must be an imbalance between calories taken in and calories burned: You either eat fewer or expend more. But in the last 30 years, new evidence has shown it is far more complicated than","nodeType":"text"},{"data":{},"marks":[{"type":"bold"}],"value":" ","nodeType":"text"},{"data":{},"marks":[],"value":"that, says Julio César Montero, a medical nutritionist and president of the Argentine Society of Obesity and Eating Disorders.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The emerging thinking among those working in this field, and reflected in a statement by the ","nodeType":"text"},{"data":{"uri":"https://academic.oup.com/edrv/article/38/4/267/3892397"},"content":[{"data":{},"marks":[],"value":"Endocrine Society","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", is that obesity is due to two related but distinct processes: the already mentioned energy imbalance (eating more calories than the body expends) and the resetting of the body weight “set point” — the weight that the body determines as its goal — to a higher value.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"People with obesity have a disorder of the energy homeostasis system, the biological process that maintains weight stability by actively matching energy intake to energy expenditure over time. Thus, the body responds to weight loss by tenaciously trying to regain the lost pounds and return to its (higher value) target weight.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"metadata":{"tags":[]},"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"cnu0m8re1exe"}},"id":"sBaiY6P1qRPekD9ezalK6","type":"Asset","createdAt":"2024-04-24T14:24:52.503Z","updatedAt":"2024-04-24T14:24:52.503Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"g-anti-obesity-medication-sites3","description":"All current FDA-approved anti-obesity medications contribute to weight loss, although the results vary from one to another. Most of these compounds act at the brain level, to reduce appetite and increase satiety, and at the gastrointestinal level, to slow gastric emptying, promote insulin release or block fat absorption.","file":{"url":"//images.ctfassets.net/cnu0m8re1exe/sBaiY6P1qRPekD9ezalK6/665801246bb53827c51792088657e379/g-anti-obesity-medication-sites3.png","details":{"size":339440,"image":{"width":1240,"height":1382}},"fileName":"g-anti-obesity-medication-sites3.png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"The mechanism behind the body’s quest to return to its body weight set point is not yet fully understood, but it explains why it is so difficult to achieve an effective treatment to manage obesity. It is estimated that only one in five people who lose between 5 and 10 percent of their initial weight through diet and exercise in six months manage to keep off the weight for more than a year. Losing and sustaining weight loss isn’t made easier by modernity’s ","nodeType":"text"},{"data":{"uri":"https://www.annualreviews.org/content/journals/10.1146/annurev.anthro.35.081705.123301"},"content":[{"data":{},"marks":[],"value":"sedentary way of life","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" and the wide range of readily available ","nodeType":"text"},{"data":{"uri":"https://knowablemagazine.org/content/article/food-environment/2023/what-can-we-do-about-ultraprocessed-foods"},"content":[{"data":{},"marks":[],"value":"ultraprocessed foods","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":". By 2035, it’s projected that ","nodeType":"text"},{"data":{"uri":"https://www.worldobesity.org/news/economic-impact-of-overweight-and-obesity-to-surpass-4-trillion-by-2035"},"content":[{"data":{},"marks":[],"value":"more than half of the world’s population","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" will be overweight or obese.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Until now, ","nodeType":"text"},{"data":{"uri":"https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00059-7/fulltext"},"content":[{"data":{},"marks":[],"value":"traditional anti-obesity drugs","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" have had limited effectiveness. Most act on brain-signaling chemicals — neurotransmitters — to reduce appetite, an approach pioneered in the 1960s with the use of amphetamines that has continued to today with safer derivatives and some other, nonamphetamine, drugs. Another often-used drug is orlistat (marketed as Alli or Xenical), which reduces fat absorption from food.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"But for all of these, the effects over the short and medium term are relatively modest, achieving a reduction of 6 percent to 10 percent of a person’s starting weight. Moreover, adverse effects, ranging from insomnia, nervousness and increased blood pressure to diarrhea and fecal incontinence, limit their widespread use.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The Role of Hormones","nodeType":"text"}],"nodeType":"heading-2"},{"data":{},"content":[{"data":{},"marks":[],"value":"In search of new ways to understand and treat obesity, in recent decades scientists have turned their gaze to the hormones secreted by the intestine.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Specifically, research has focused on ","nodeType":"text"},{"data":{"uri":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1642697/"},"content":[{"data":{},"marks":[],"value":"a group of 10 hormones","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" that have roles in optimizing the process of digestion and absorption of nutrients from the food we eat. They are also how the gastrointestinal tract sends signals to the brain about the body’s energy status, in many cases influencing metabolism and contributing to the regulation of our appetites.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The new strategy “has changed the therapeutic landscape of obesity to target underlying mechanisms” and spurred “","nodeType":"text"},{"data":{"uri":"https://www.annualreviews.org/doi/10.1146/annurev-med-043021-014919"},"content":[{"data":{},"marks":[],"value":"an auspicious new era of highly effective drugs","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":",” write endocrinologist Ania Jastreboff of Yale School of Medicine and her colleague Robert Kushner of Northwestern University in a 2023 article in the ","nodeType":"text"},{"data":{},"marks":[{"type":"italic"}],"value":"Annual Review of Medicine","nodeType":"text"},{"data":{},"marks":[],"value":".","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"One such hormone is glucagon-like peptide type 1, or GLP-1, discovered in the 1980s. Semaglutide, the active molecule in Ozempic and Wegovy, is a lab-made lookalike that mimics the action of GLP-1. Like GLP-1 itself, and like an earlier drug, liraglutide, that was approved in 2010, it suppresses the release of glucagon — a hormone secreted by the pancreas to raise blood sugar levels. It also promotes the growth and function of pancreatic beta cells, which are responsible for producing insulin, the hormone that ensures that sugar from food enters the body’s cells to give them energy.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Both of these actions regulate blood sugar levels, which is why these drugs were initially intended to tackle diabetes. A series of ","nodeType":"text"},{"data":{"uri":"https://pubmed.ncbi.nlm.nih.gov/30615985/"},"content":[{"data":{},"marks":[],"value":"clinical trials called SUSTAIN","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", which evaluated the drug in about 8,000 patients with type 2 diabetes, showed that semaglutide is more effective than other available drugs (sitagliptin, marketed as Januvia; exenatide, or Byetta; dulaglutide, or Trulicity; and insulin glargine, or Lantus) in reducing ","nodeType":"text"},{"data":{"uri":"https://diabetes.org/about-diabetes/a1c"},"content":[{"data":{},"marks":[],"value":"glycosylated hemoglobin","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" scores — a test that measures average blood glucose levels over the prior three months. Maintaining blood sugar levels within the target range is a goal in the treatment of diabetes to avoid complications.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"But it was soon realized that these drugs came with a bonus, since GLP-1 doesn’t act only on the pancreas. It also acts on centers in the brain that control appetite. And it decreases stomach movements and emptying, so people feel full for longer. These two mechanisms contribute to reducing food intake, but, unlike older anti-obesity drugs, “they do so in a more physiological way, with few adverse effects,” says Montero. One of the best effects, he adds, is that they take away suffering, because they assuage food cravings. ","nodeType":"text"},{"data":{"uri":"https://pubmed.ncbi.nlm.nih.gov/36655300/"},"content":[{"data":{},"marks":[],"value":"Patients report","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" a reduced desire to eat highly seasoned and salty foods, or foods rich in carbohydrates, as well as a better ability to resist urges.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"metadata":{"tags":[]},"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"cnu0m8re1exe"}},"id":"xg6VbquwzpLZ1la4VClcM","type":"Asset","createdAt":"2024-04-24T14:25:32.951Z","updatedAt":"2024-04-24T14:25:32.951Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"g-glp1-body-tissues","description":"Semaglutide, the active molecule of Ozempic and Wegovy, is a synthetic version of glucagon-like peptide type 1 or GLP-1. The functions of GLP-1 in the body are numerous, acting on the pancreas, stomach, gastrointestinal tract, kidneys, bones, heart, liver, muscle and adipose tissues, the energy-regulating center of the brain, and the rest of the neural system.","file":{"url":"//images.ctfassets.net/cnu0m8re1exe/xg6VbquwzpLZ1la4VClcM/bcaf3c49d18002bbfa11428d955e4bf1/g-glp1-body-tissues.png","details":{"size":292636,"image":{"width":1540,"height":1326}},"fileName":"g-glp1-body-tissues.png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"For Harwicz, semaglutide can be a facilitator that helps people make better decisions. One of her patients, a man weighing more than 160 kilograms (over 350 pounds) with a history of diabetes who had failed multiple previous attempts to lose weight, was able to lose 35 kilos (77 pounds) — more than 20 percent of his body weight — with weekly injections of the drug, along with dietary education and a tailored physical activity plan. “He really feels like he’s succeeding because the medication is helping him,” she says. “It’s important to modify lifestyle; medication isn’t magic. But people can make better food choices and reduce the amount they eat with a lot more peace of mind.”","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Of course, like any drug, semaglutide does not work in all patients, nor is it tolerated by all. In the SELECT study, for example, 16.6 percent of participants receiving semaglutide dropped out of the trial because of adverse effects, mainly digestive problems such as nausea, vomiting and diarrhea.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"More in the Pipeline","nodeType":"text"}],"nodeType":"heading-2"},{"data":{},"content":[{"data":{},"marks":[],"value":"Everything indicates that the injections of semaglutide are just the beginning in this new era of weight loss drugs. In addition to a ","nodeType":"text"},{"data":{"uri":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01185-6/abstract"},"content":[{"data":{},"marks":[],"value":"high-dose oral version of semaglutide","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" that showed promising effects in trials and is on the horizon for approval, a tsunami of clinical trial results is anticipated for new drugs that also operate on the gut-brain axis and re-create the action of other intestinal and pancreatic hormones.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"One of these is glucose-dependent insulinotropic polypeptide (GIP), which promotes insulin release after meals and reduces appetite. Another hormone is glucagon, which counterbalances the action of insulin by raising blood sugar, helps eliminate fat from the liver and increases satiety. And a third is amylin, which delays stomach emptying, accelerates satiety and decreases the desire to eat.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Collectively, such therapies have been dubbed “nutrient-stimulated hormone-based treatments” because they mimic the action of hormones that are released or function when specialized sensor cells in the digestive tract detect food intake. And they promise to enhance slimming effects, alone or in combination, partly through a physiological reset that prevents the body from stubbornly returning to a weight range that seems predetermined. In other words, it reduces the body’s tendency to regain the lost pounds.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"One of the newer drugs, tirzepatide from Eli Lilly (marketed as Mounjaro or Zepbound), acts both on GLP-1 and GIP receptors. It ","nodeType":"text"},{"data":{"uri":"https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management#:~:text=Today%2C%20the%20U.S.%20Food%20and,weight%2Drelated%20condition%20(such%20as"},"content":[{"data":{},"marks":[],"value":"obtained FDA approval November 2023","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" for the treatment of obesity. ","nodeType":"text"},{"data":{"uri":"https://jamanetwork.com/journals/jama/fullarticle/2812936"},"content":[{"data":{},"marks":[],"value":"One of the clinical studies","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" of this drug reported an average decrease of 25.3 percent of initial weight in those who received a weekly injection for 88 weeks.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Another experimental drug from Eli Lilly, retatrutide — dubbed “triple G” because it acts on GLP-1, GIP and glucagon receptors — could be next on the list. Last June, a study led by Jastreboff ","nodeType":"text"},{"data":{"uri":"https://www.nejm.org/doi/full/10.1056/NEJMoa2301972"},"content":[{"data":{},"marks":[],"value":"reported weight declines never before seen with a single drug","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":". Patients without diabetes averaged a 24 percent body weight loss in just 48 weeks (11 months). And in the group receiving the highest dose, one-fourth of the patients dropped more than 30 percent of their weight. That’s close to the results of highly effective, but more drastic, bariatric surgery.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"“I never imagined that physicians would have to worry about our patients losing ","nodeType":"text"},{"data":{},"marks":[{"type":"italic"}],"value":"too ","nodeType":"text"},{"data":{},"marks":[],"value":"much weight when taking an anti-obesity drug,” Kushner says. “This is really an interesting turning point in obesity science and practice, an important paradigm shift in how we think about and manage people living with obesity.”","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Kushner and Jastreboff suggest in their article that combining various members of these hormone-based drugs could target the many intertwined mechanisms of obesity. Montero agrees: “There is a swarm of hormones that form a spider web. And touching more than one thread at a time may move the web better, potentiating the effect and making interventions more comfortable, with fewer adverse events,” he says.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"metadata":{"tags":[]},"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"cnu0m8re1exe"}},"id":"7bOiOQ7aTX0LueweY9HWSx","type":"Asset","createdAt":"2024-04-24T14:26:04.012Z","updatedAt":"2024-04-24T14:26:04.012Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"g-major-gut-hormones3","description":"A number of gut hormones have attracted scientific attention as potential therapeutic targets for the management of obesity.","file":{"url":"//images.ctfassets.net/cnu0m8re1exe/7bOiOQ7aTX0LueweY9HWSx/65929ba3ce114acd55bbb5b677f328ee/g-major-gut-hormones3.png","details":{"size":237092,"image":{"width":1540,"height":2904}},"fileName":"g-major-gut-hormones3.png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"What is more, semaglutide and tirzepatide could also have benefits in other diseases, such as ","nodeType":"text"},{"data":{"uri":"https://www.nature.com/articles/s41598-023-48267-2"},"content":[{"data":{},"marks":[],"value":"alcohol abuse disorder","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" and other compulsive or addictive behaviors, such as smoking, excessive shopping and nail-biting. The drugs also ","nodeType":"text"},{"data":{"uri":"https://www.kidney-international.org/article/S0085-2538(23)00756-1/fulltext"},"content":[{"data":{},"marks":[],"value":"reduce inflammation","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", which could help to limit damage to various organs and structures, such as the kidneys and joints. There are also preliminary studies of the effects of the drug in preventing ","nodeType":"text"},{"data":{"uri":"https://onlinelibrary.wiley.com/doi/10.1002/oby.23772"},"content":[{"data":{},"marks":[],"value":"cancer","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", and for the treatment of ","nodeType":"text"},{"data":{"uri":"https://pubmed.ncbi.nlm.nih.gov/30741689/"},"content":[{"data":{},"marks":[],"value":"Parkinson’s","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" and ","nodeType":"text"},{"data":{"uri":"https://pubmed.ncbi.nlm.nih.gov/37730113/"},"content":[{"data":{},"marks":[],"value":"Alzheimer’s","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", although further studies are still needed to confirm their results. Writing in 2023, the editors of the journal ","nodeType":"text"},{"data":{"uri":"https://www.aaas.org/news/sciences-2023-breakthrough-glp-1-agonists-show-promise-against-obesity-associated-disease"},"content":[{"data":{},"marks":[{"type":"italic"}],"value":"Science","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" declared that no scientific breakthrough in that year had been so transformative in so many fields, affecting everything from financial markets to popular culture.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"But, as with any medical innovation, unavoidable challenges also loom on the horizon. Although the visible adverse effects of GLP-1 receptor agonists — nausea, vomiting, constipation and diarrhea — are usually mild and limited to the gastrointestinal tract, other more unusual but serious complications have raised concerns, such as a possible increased risk of pancreatitis. In addition, animal studies (not yet demonstrated in humans) suggest that there is a link to thyroid cancer risk.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Another barrier is the cost of these drugs. In the United States, a monthly treatment with semaglutide costs almost $1,000; the price drops almost 10-fold in countries such as Japan, the United Kingdom and Australia. In Latin America, where obesity rates have grown faster than in other parts of the world, the drug remains unaffordable for the bulk of the population. In Argentina, for example, in March an Ozempic pen with four doses of 1 mg cost 409,000 pesos, which is equivalent to more than twice the monthly minimum wage. More than two pens per month would be required to reach the 2.4 mg per week dose used in the SELECT cardiovascular prevention study.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"To make matters worse, studies show that the benefits on weight fade or diminish sharply when the treatment is stopped, so it would have to be continued long-term. Research published in 2022, for example, found that patients ","nodeType":"text"},{"data":{"uri":"https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14725"},"content":[{"data":{},"marks":[],"value":"regained two-thirds of their lost weight within a year of stopping medication.","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"“Our enthusiasm as clinicians with these drugs wanes if you think about it from a public health point of view,” says Patricio López Jaramillo, an endocrinologist, researcher and rector of the University of Santander in Bucaramanga, Colombia. He thinks that the use of the drugs should be placed within a broader societal package that extends beyond “the rational, linear and disciplinary vision” of medical specialists.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"“New anti-obesity drugs should be considered as a useful tool, if financial access is improved,” he says. “And [use] must be framed within global actions and programs that allow populations to have real possibilities to practice healthy lifestyle habits, such as exercising, following a balanced diet and staying away from smoking.”","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Kushner says physicians need to reexamine the kind of lifestyle advice given to people receiving these new drugs, de-emphasizing calorie counting and daily weigh-ins. More focus should be placed on health impacts rather than weight loss, high-quality protein intake should be encouraged, and the importance of physical activity and resistance exercise to preserve muscle mass should be emphasized.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"One option could be to use tests to predict which patients will have better results with the various medications and who, perhaps, should think about surgery or other approaches. “Not all patients respond to treatment,” says Andrés Acosta, an Ecuadorian physician and researcher who heads the ","nodeType":"text"},{"data":{"uri":"https://www.mayo.edu/research/labs/precision-medicine-obesity/overview"},"content":[{"data":{},"marks":[],"value":"Precision Obesity Medicine Laboratory","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" at the Mayo Clinic in Rochester, Minnesota. It is important to identify those who would benefit most, he adds.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Acosta cofounded a company that last year launched a test that identifies patients with a feature called “hungry gut” — those who move food quickly from their stomachs and, consequently, lose satiety faster. This could be a subgroup that particularly benefits from these new anti-obesity drugs, he hypothesizes. For a drug market that could be worth $100 billion by 2030, it wouldn’t hurt to ensure that resources are invested in the patients who will get the most from them.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"italic"}],"value":"Editor’s note: This article was updated on April 17, 2024, to correct the location of the Mayo Clinic. It is in Rochester, Minnesota, not Rochester, New York, as originally stated.","nodeType":"text"},{"data":{},"marks":[],"value":" ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[],"nodeType":"hr"},{"data":{},"content":[{"data":{},"marks":[{"type":"italic"}],"value":"10.1146/knowable-041724-1","nodeType":"text"},{"data":{},"marks":[],"value":" ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"},{"type":"italic"}],"value":"Matías A. Loewy","nodeType":"text"},{"data":{},"marks":[{"type":"italic"}],"value":" is a science journalist based in Buenos Aires, Argentina. He remembers that when he was a pharmacy student at the University of Buenos Aires, the only treatments for obesity were based on dangerous amphetamine derivatives. For now, he keeps his weight more or less under control. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"italic"}],"value":"This article originally appeared in ","nodeType":"text"},{"data":{"uri":"https://knowablemagazine.org/content/article/health-disease/2024/whats-next-in-the-ozempic-era"},"content":[{"data":{},"marks":[],"value":"Knowable Magazine","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[{"type":"italic"}],"value":", an independent journalistic endeavor from Annual Reviews.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"document"}},"related":[{"image":{"description":"(Credit: fcm82/Shutterstock) ","id":"7n3BzbrVbzriEbi7o2UuDQ","title":"Pen injection of semaglutide named “ozempic”, is a diabetes medicine to improve blood sugar","url":"//images.ctfassets.net/cnu0m8re1exe/7n3BzbrVbzriEbi7o2UuDQ/c0cb7a5856c717f1915801195f5ca274/ozempic-semaglutide-weight-loss.jpg"},"refs":{"category":{"image":{},"sortOrder":1,"name":"Health","id":"1TljbtPL83DpobaGeEmgsc","hideRightRail":false,"slug":"health"},"tags":[{"image":{},"name":"human body","id":"1cU3gDw3v3iEIg7X95hhiu","hideRightRail":false,"slug":"human-body"},{"image":{},"name":"wellness","id":"7ggDYP0OTNwUy9rp0E11oy","hideRightRail":false,"slug":"wellness"},{"image":{},"name":"personal health","id":"26gE2zR2g1qvDAP4gZiDSq","hideRightRail":false,"slug":"personal-health"},{"image":{},"name":"obesity","id":"2SUGPrvL4VjXvrajil3Lke","hideRightRail":false,"slug":"obesity"}]},"meta":{"template":"Standard","publicationDate":"2024-05-02T13:00-05:00"},"subtitle":"The active ingredients in these popular type 2 diabetes treatments are being used to treat a wide range of health conditions. Here's what sets them apart.","id":"7KVQpyh5h4X2ACiDzQ6TuW","title":"The Difference Between Zepbound and Ozempic, and How They Work","slug":"the-difference-between-zepbound-and-ozempic-and-how-they-work"},{"image":{"description":"(Credit: Artem Stepanov/Shutterstock","id":"7lcnWppZP1N5j4iMuG4VDx","title":"Weight Loss Pills Scattered from Bottle on Yellow Background","url":"//images.ctfassets.net/cnu0m8re1exe/7lcnWppZP1N5j4iMuG4VDx/517bef5352c52d68b0b3b6827f296e9b/weight-loss-pills.jpg"},"refs":{"category":{"image":{},"sortOrder":1,"name":"Health","id":"1TljbtPL83DpobaGeEmgsc","hideRightRail":false,"slug":"health"},"tags":[{"image":{},"name":"wellness","id":"7ggDYP0OTNwUy9rp0E11oy","hideRightRail":false,"slug":"wellness"},{"image":{},"name":"human body","id":"1cU3gDw3v3iEIg7X95hhiu","hideRightRail":false,"slug":"human-body"},{"image":{},"name":"obesity","id":"2SUGPrvL4VjXvrajil3Lke","hideRightRail":false,"slug":"obesity"},{"image":{},"name":"medicine","id":"63zqJDcfNZHhs0Ua4pUV2L","hideRightRail":false,"slug":"medicine"}]},"meta":{"template":"Standard","publicationDate":"2024-04-30T13:00-05:00"},"subtitle":"Research has shown some benefits to different types of weight loss drugs. Here’s how they work — and the potential side effects to be aware of.","id":"5VEcWhb7Z9h4YOcTb72QcP","title":"These 10 Weight Loss Drugs Like Ozempic Can Work, but Are They Safe?","slug":"these-10-weight-loss-drugs-like-ozempic-can-work-but-are-they-safe"},{"image":{"description":"Witthaya Prasongsin/Moment via Getty Images","id":"476MnWfbAZnUfxZu4Ewb3M","title":"file-20240403-18-ou3is0","url":"//images.ctfassets.net/cnu0m8re1exe/476MnWfbAZnUfxZu4Ewb3M/056357c0982a49fbac53a94ef5bc44eb/file-20240403-18-ou3is0.jpg"},"refs":{"category":{"image":{},"sortOrder":1,"name":"Health","id":"1TljbtPL83DpobaGeEmgsc","hideRightRail":false,"slug":"health"},"tags":[{"image":{},"name":"wellness","id":"7ggDYP0OTNwUy9rp0E11oy","hideRightRail":false,"slug":"wellness"},{"image":{},"name":"human body","id":"1cU3gDw3v3iEIg7X95hhiu","hideRightRail":false,"slug":"human-body"}]},"meta":{"template":"Standard","publicationDate":"2024-04-27T08:00-05:00"},"subtitle":"Nearsightedness is also known as myopia.","id":"4IBn3S8d0YEasQLg4xuMpQ","title":"Nearsightedness Is at Epidemic Levels and the Problem Begins in Childhood","slug":"nearsightedness-is-at-epidemic-levels-and-the-problem-begins-in-childhood"}],"more":[{"image":{"description":"nikamo/Shutterstock.com","id":"11wxpTGx7bKFCG6NN6ot9l","title":"file-20190925-51463-xb6xey","url":"//images.ctfassets.net/cnu0m8re1exe/11wxpTGx7bKFCG6NN6ot9l/34ff00a02818397820ae9f8f5c9055a7/file-20190925-51463-xb6xey.jpg"},"refs":{"category":{"image":{},"sortOrder":1,"name":"Health","id":"1TljbtPL83DpobaGeEmgsc","hideRightRail":false,"slug":"health"},"tags":[{"image":{},"name":"microbiome","id":"57lGUJb2BTApAPrZEZOiOS","hideRightRail":false,"slug":"microbiome"}]},"meta":{"template":"Standard","publicationDate":"2024-05-04T08:00-05:00"},"subtitle":"Drinking alcohol isn’t the only cause of high blood alcohol levels. ","id":"4A2OT5ODPU1GeD3rD8ExVh","title":"Gut Microbes That Get You Drunk And Damage Your Liver","slug":"gut-microbes-that-get-you-drunk-and-damage-your-liver"},{"image":{"description":"(Credit: Inside Creative House/Shutterstock) ","id":"6NfOSp33kO8kgs7E3RTbzh","title":"older man taking an eye exam","url":"//images.ctfassets.net/cnu0m8re1exe/6NfOSp33kO8kgs7E3RTbzh/33ea3748a358f86988447c57438fba89/old-man-eye-exam.jpg"},"refs":{"category":{"image":{},"sortOrder":1,"name":"Health","id":"1TljbtPL83DpobaGeEmgsc","hideRightRail":false,"slug":"health"},"tags":[{"image":{},"name":"human body","id":"1cU3gDw3v3iEIg7X95hhiu","hideRightRail":false,"slug":"human-body"},{"image":{},"name":"personal health","id":"26gE2zR2g1qvDAP4gZiDSq","hideRightRail":false,"slug":"personal-health"}]},"meta":{"template":"Standard","publicationDate":"2024-04-29T08:00-05:00"},"subtitle":"Advanced age is a risk factor for blindness, but there’s a lot you can do to protect your vision before it’s too late.","id":"6OZIwKwGoCb8qypEfBwY9U","title":"Here’s How To Avoid These 3 Types of Age-Related Vision Loss","slug":"heres-how-to-avoid-these-3-types-of-age-related-vision-loss"},{"image":{"description":"SBenitez/Moment via Getty Images","id":"2uo8BLQcQpKzOH4FXTFfFU","title":"file-20240329-16-2tyzfc","url":"//images.ctfassets.net/cnu0m8re1exe/2uo8BLQcQpKzOH4FXTFfFU/be38a044b27447b71687fbdaa70dc6a5/file-20240329-16-2tyzfc.jpg"},"refs":{"category":{"image":{},"sortOrder":1,"name":"Health","id":"1TljbtPL83DpobaGeEmgsc","hideRightRail":false,"slug":"health"},"tags":[{"image":{},"name":"wellness","id":"7ggDYP0OTNwUy9rp0E11oy","hideRightRail":false,"slug":"wellness"}]},"meta":{"template":"Standard","publicationDate":"2024-04-26T09:00-05:00"},"subtitle":"Certain chemicals in synthetic fabrics such as spandex, nylon and polyester can alter the skin microbiome.","id":"PqlRDqhRRsogtzrS5dHdZ","title":"Chemical Pollutants Can Change Your Skin Bacteria, Increasing Eczema Risk","slug":"chemical-pollutants-can-change-your-skin-bacteria-increasing-eczema-risk"},{"image":{"description":"(Credit: Marilyn Barbone/Shutterstock)\n","id":"3MIWHsJjKBWQvpaTLhSDcO","title":"Foods with high fiber","url":"//images.ctfassets.net/cnu0m8re1exe/3MIWHsJjKBWQvpaTLhSDcO/053fa836bcf9499414ee50723e0dde48/food-with-high-fiber.jpg"},"refs":{"category":{"image":{},"sortOrder":1,"name":"Health","id":"1TljbtPL83DpobaGeEmgsc","hideRightRail":false,"slug":"health"},"tags":[{"image":{},"name":"microbiome","id":"57lGUJb2BTApAPrZEZOiOS","hideRightRail":false,"slug":"microbiome"},{"image":{},"name":"personal health","id":"26gE2zR2g1qvDAP4gZiDSq","hideRightRail":false,"slug":"personal-health"}]},"meta":{"template":"Standard","publicationDate":"2024-04-25T13:00-05:00"},"subtitle":"How long does it take to improve your gut health? Learn what research is saying and how you can reset your microbiome through diet.","id":"HK8tHyUM9r1iZ2crZEbOS","title":"It Doesn't Take Long to Reset Your Gut Health With Small Lifestyle Changes","slug":"it-doesnt-take-long-to-reset-your-gut-health-with-small-lifestyle-changes"},{"image":{"description":"(Credit: fcm82/Shutterstock)","id":"1QS4LJKQQpT5ljx6sFen73","title":"ozempic shot","url":"//images.ctfassets.net/cnu0m8re1exe/1QS4LJKQQpT5ljx6sFen73/7e378788e522957aff697886f4e8ca0b/ozempic-shot.jpg"},"refs":{"category":{"image":{},"sortOrder":1,"name":"Health","id":"1TljbtPL83DpobaGeEmgsc","hideRightRail":false,"slug":"health"},"tags":[{"image":{},"name":"wellness","id":"7ggDYP0OTNwUy9rp0E11oy","hideRightRail":false,"slug":"wellness"},{"image":{},"name":"drugs \u0026 addiction","id":"CXZIgWdhnxXaXJeWL17Qd","hideRightRail":false,"slug":"drugs-and-addiction"},{"image":{},"name":"human body","id":"1cU3gDw3v3iEIg7X95hhiu","hideRightRail":false,"slug":"human-body"}]},"meta":{"template":"Standard","publicationDate":"2024-04-23T10:00-05:00"},"subtitle":"Everyone has been talking about Wegovy and Ozempic for weight loss. But Semaglutide could be used for heart conditions and even alcohol use disorder.","id":"12gsemboz1B8kRglatc3Zz","title":"Beyond Weight Loss and Diabetes, Ozempic Could Help Certain Heart Conditions","slug":"beyond-weight-loss-and-diabetes-ozempic-could-help-certain-heart-conditions"},{"image":{"description":"(Credit: aslysun/Shutterstock)","id":"2uoq2xi5cu8nhoBFmic4l1","title":"close up of a young woman holding a bubble tea at a restaurant ","url":"//images.ctfassets.net/cnu0m8re1exe/2uoq2xi5cu8nhoBFmic4l1/6b43125ac60fa098cbf1849f0616d8a9/Bubble-milk-tea.jpg"},"refs":{"category":{"image":{},"sortOrder":1,"name":"Health","id":"1TljbtPL83DpobaGeEmgsc","hideRightRail":false,"slug":"health"},"tags":[{"image":{},"name":"food science","id":"6QomFR7yEQAoaipgSiLR4S","hideRightRail":false,"slug":"food-science"},{"image":{},"name":"wellness","id":"7ggDYP0OTNwUy9rp0E11oy","hideRightRail":false,"slug":"wellness"},{"image":{},"name":"culture","id":"1WNyvQXJ9xoupuucpLtn7k","hideRightRail":false,"slug":"culture"},{"image":{},"name":"personal health","id":"26gE2zR2g1qvDAP4gZiDSq","hideRightRail":false,"slug":"personal-health"}]},"meta":{"template":"Standard","publicationDate":"2024-04-23T08:00-05:00"},"subtitle":"Bubble or boba tea is hugely popular, but what is it made of and is it really good for you?","id":"1do2C3uFCCXMMrexKB6O1F","title":"Does Bubble Tea Have Any Health Benefits?","slug":"does-bubble-tea-have-any-health-benefits"}],"products":[{"id":"4XJH8DuetDVvwNielffDcF","name":"Periodic Mug","targetUrl":"https://myscienceshop.com/product/gift/82404","image":{"id":"1vKxEHsuFiRApZArXMSiKE","title":"Periodic Mug","url":"//images.ctfassets.net/cnu0m8re1exe/1vKxEHsuFiRApZArXMSiKE/1aad4b21254375cbcb09021be286440d/82404a.jpg"},"sortOrder":1},{"id":"WXEls87yltppCxevkwgPD","name":"Foucault's Pendulum","targetUrl":"https://myscienceshop.com/product/stem-toy/82402","image":{"id":"2tiN4OwifJHq9jdvqS3udB","title":"Foucault's Pendulum","description":"","url":"//images.ctfassets.net/cnu0m8re1exe/2tiN4OwifJHq9jdvqS3udB/a2d786f4f74ed6a5a62f2ec2e24e8b13/82402.jpg"},"sortOrder":4},{"id":"5e9hmYLIEFDcRCphXRBKuk","name":"Discover STEM Kits","targetUrl":"https://myscienceshop.com/catalog/stem-toys?filters=d45e08f03e9445408452b70ccbacfd9d","image":{"id":"1LJQgCEQ07e7YwLXnEJv4Q","title":"Discover STEM Kits","url":"//images.ctfassets.net/cnu0m8re1exe/1LJQgCEQ07e7YwLXnEJv4Q/9960323864cfa47e536ec19baf958824/82308.jpg"},"sortOrder":3},{"id":"4UZTdwy9zUaYQ63ybzseBX","name":"Elements Flashcards","targetUrl":"https://myscienceshop.com/search?q=Elements+Flashcards","image":{"id":"1VgN2t8uhhk2laXnkfWcVp","title":"Elements Flashcards image","url":"//images.ctfassets.net/cnu0m8re1exe/1VgN2t8uhhk2laXnkfWcVp/bc3523f797e745e300c97ef4f7b18ea2/66412_elements_bundle.JPG"},"sortOrder":2}]}},"__N_SSP":true},"page":"/health/[[...slug]]","query":{"slug":["whats-next-in-the-ozempic-era"]},"buildId":"my-build-id","isFallback":false,"isExperimentalCompile":false,"gssp":true,"scriptLoader":[]}</script></body></html> contentType 9 text/html url 73 https://www.discovermagazine.com:443/health/whats-next-in-the-ozempic-era responseCode 3 200 